var title_f13_14_13536="Venous stasis ulcer";
var content_f13_14_13536=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F71020&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F71020&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Venous stasis ulcer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 214px; height: 271px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEPANYDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDzq9gMU5MYxzzVmym3OCT0rQ1C1An5BAJNYsytbyZHSvuNj5qL9pFI6mzfeM46H86lnfcRwMjtWfo83mIcevap7h/34FBxShaVidSDjH44qG+X9y+B9anQDAx1NJeKfJPHBHWglbnnuuu0TFl5IboawgqzyByFKlsAj0HWtvxOjAMQD97gZ68dKyLWQBxvZRGDnHrXz+ZfxT7PLf4SaI7u2BA8oDHYevtU0UaeWigDcFzk96u+SkrxSqxOCSB25qRY2jwzQgg8A8Yx61404nrRloVY7aPb+7ifOchicZ9q6XTLeITo7P03DJY7h+vf2rnEmZ0YBSxyQApxgeoNb+jSJFcl5Xj28fKV4Azk4Prx/Ooi1c2cXY7DTbhmto2lA2F8AKcFTjPpnj+tdfb3UzLNdXc0q3DAI04UllHGOT+X41zGjMJLh52XJDHMYxsQcHIPt2zXXaT5rzyTvHCiypiKNo94BB5747Gu6jJ3sjlrRSV2bOnMbOCVU+0SXjSHzEj5BHcEgd8A/iaztddi6yeW6BRsDAA7sgLg56NnP51ufYprKz8uW7w0qnCxrnJ5xvwMZ5xjkYHesnxBixljDSG6jkdkZnwAcEdvTBBHp+ddMloctOScro47VsRT3nlXASJGICgLgttB78c9MYrzzUZ3hR8iMBSVDgdF9f0PNdnr8oi34MrEgbl3YBGOmP6153q07NbSBppN7bmP90H+7x6GuKq9TvhFWMe6vjGxCSLkjlQM4wOOffmux+Cl8z+J79HAw1oX+mHUf1NedGFpCX3A8Z5IH6V3nwWhK6/qDsORbYyD6uP8KvAtvER+f5HBncUsDU9P1Po7RW862dQMMhyD9f8A9VW95QDoMVgaPc+XdRjjDYX+f+NdFdw7cOOgOK92WjPzaKvG6JQxC5yckdamjVlhcnkVWwfLGTzVx5AlqQT1FZtmkUbOiybrcLngDFXpHwenFZXh9g8OR0rQuHEf3jXFUXvs9Ol/CTKtwAX+UflRWVeaiVlxCpYd8UV0Rg7HHOpG54dPEJ/l7j2rnNUsyEPqK6uCLEhbuapalanyyQOte3foXSquDscrp9y1vLgnHNbCTLIwY98VmX9r5f7xOg7UtnKWiABwV4prsdc4xmuZHQxgSKDnkVM4zCwzms62mCxgnn2rQRx5fIOCKTRySVmcH4uiUQMc8h65OKQR38TdAnP+y3tiu38YJ/oUjEDg5rgYwGk8tTySDk14Waq00z6/J5c1I3Y2jeTfHkbjypXA/wD1V0VnbB7bzNocf3ewNY2lxBrZjhcgADgn8q6DTpSbQeWCx3bSAMY/zzXkNaHr2uZ/2GSK53bCu056fJuAzg1NZWjG7wsZUt8u48gHI59sDPSumgsFklWO7bEeA+YnDAnIzhumcZ7VYfU9M8kQ2tuUlhwiAqH35GDuPv60lSXV2NvaNbK5Z0q3jW3uBJcNHOpwoIySARkZx15/HtXU2Oo/YbXyl/e3MRwokHmBlJzyfbJ/SudivVjdzLDG7hjmN0Ofoef5c9fpXpXh6TTZIGubRGMZG3CQbShz1AznJ7+1ddKK2izlr1LayVytBqL6vCzAAF1x+9fAA5HygcZznrzTtV0ef+zbVJmQCJHzJHyWB45PXPHatHRdFgW3Fza3EiNFKzvtUqDzkowHB5Xg+59TWzexwNZ3FukqoZyCxAKvt4/pnmuiKutTgnVUZWhsfN/jVp4NRnsJnLQxbQGVAHYYGAWyfXpmuQurM3drJCZVj+bzB1GexB/SvSfEulxjULlsyPOfmU442gYH48Vwt6YvtPkx4LlzGVfjJ5HGa46sNbM9WlK8Tlbq1+xoQoZgwOW2/pXVfBNwfFN9Bz89qWH4Ov8AjWB4lneVSqxhY1IGVzjtWv8ABV9vjWTd1NpIB/30tLC+7XjY5M4XNgal+x7tFGVkQ5wQRjHau0SXz9PhbscA1yAOJFHqa6DSpw1i8T9Yyx/r/WvdqK5+b0nZtCXF8kbbQcleCaoz37uhC56VFHbyTDexwD8xNWBZbRyKLJGTcpHWeDX8zTwzHmp9ectJEqHBzVHwk22OWMfw1oSr9onEnccVxyVqrZ6cHegoohCLEoUgA0UlxCQ/Lsc0Va1MndO1jxhlAUcdahK5OCMirEJ3Nk4OBTJYwDuU4r2jBMyr21WQOAMAriuZurZradtnIJrsZQSpVevc1l3dt5hKuOe1Ujqo1eXcybeQlOuK0YJmKjnpWNKjwvgdBV2xnV2AOBnjrTOicU1dFLxPtfT5ywzwcflXDafbQpLbtc7h5j7SykZC9M8j1Ndrr6/u5Fz8pB47dK5MWYbTmdpP3iYUSuwxGjN8xx+A6V5GZRu0z3cply02jWlk/spLaOO2kltZ2cqyNuJI5ycdCeeK1pbuSxujAFL/ADFd0ZBXGcZJzj8qoWNzolzp8Vtf6i9u8YQebGGIO0EfdHJzwc+3vkWnaCy1KLPl3MNyY0VARjJ7Ek4HcZHofx8ydPS6PRjWadnuas908sHm2+UUtnaDuHucf1rVDW4ZTDZyEyEArgEr6nj86zdT1nTrG6eAQyQRRYKqjblQHuAcEjJ64/E0yy1x7q5aaxuoGkDL1RQSv8XPpx6f/Xz5I81mbqtJwujvtOggkBeSDH3WKv6/zxXUaVBBp8xlsAyzMu1uS64z7159pPiC4smT7bM9wr87ZGywUj74YZwPbj6V6DpGoW968ZiZ3mbO5MgOBzjuR2NdlJRe25yVqjtrsdHaXxt0TztgLkJnIUnP9frTL68jkcSTeVyD5alSGXHHUdent+tZn21N7rcuI+cBWzz9Pwx7VT1SSE27ujNgDHmbumfTv39K0cUtTGCu9TM8Tw288dwUg3B4RHHIsZDF89Mhsgdffv1rwrxBp4try3dZoncqXbg7lJ7ZP9K9dbU7dTHNFqCRztECsDR7tpznzApG0jOcr16nkVy2qrZapGyMlvDcJC/k7UySwUlRzyTkYP19q468VUWm562GvT0ex5DqsrR5Rg4XqPetv4Py/wDFdwDJ+eKQfpn+lY+u2rxTMJxtkGMg9RxVr4ZiRfHmniFwrES8n/rm1cmGb9vBeaDNo/7HVt/K/wAj6TIO7dz8uK0dMkZJ3K8B1OR7cVRxlCV7ir1hGQysSMYxX0j2PyxPU2VRP3YAG1uPwou4GiTnvwDSQvlgrEcdK1JlWW2ZcjPasHozoSUkyLw6fJuWX++ma1pYpY3z90H0rI09NkwU/eUEV09uRcQbTywrnrPlfMdWH9+PKULghdmAScc0VPMACAw5HHNFSnoOS13PBbIELuPIqR+ecUtjg2ytxyBSMPmOK9/qcXUiYDcQPzqrLGC5ByferTqRgdz3qIqVY0FJmFfWYBJArGZGhfK5A659K664j3bgee1YtxCPnQrwatanXRq9Gc/eXBmGx+S3B/KuE1SWS2VkRyFbqOPT/wCvXdzWzJcg44DVx/ie1LavFaoPmkKqB9a8vNIt0uZdD6PK5RVTkXVGfo8X2qdSysVGQSV3Aceneu207wVd65BuiLBQu5Uzgr2AxVeylt9BjgEVvDcGJR5ocYLSEcgeoHr/APWrel8WateXs13bA28TBWaG2XCqoHQnn3596+WniqVNe+z7XCZNXxUrrRWMnVvCPiWyeSSSz1B3kiG5seYMHnlh9K5m3vrnTZ3E1mDGpGUKfKO+K9jsPGPiS8sRbPMqREearmH5fUAkjOPesea007WreFNUhFqLlmb7THwCeeSD6nFJYmlOS5J6vuXUyOvTg+ZJ27FHTdf07VJvLllhtI4o0UeeQXBGR8u0DjkYGDjB9a72NpbS6jTS7sSAjKqxjjkPXO5dwx09uMe9ee6l8PofPH9mXMc6sxYscKRgjrzg9RVvxB4e8U2egrdvcXCOp8sxTpu2sWB+U9Bleec9G9q9OlXcYtyW3Y+bxOClCaW3qez6ZeR3tuy6lCiyR/Km/IDjJA6nI5Uj8OPQUtUEckc/2WR8jIbL4+gABPGPpweCe3G/DTxTJIsllq2mRXdzDJveb7XHbuMkEjy8KCvOevUn1ONHxDr1lZa0bVbqa0SQsZI54SpC5OTnPODuHHJ28DPXp54zjzHPSvTqcrOZ1uKOcun7mMHDrKsYBHHC5BxjP689OK527a/sp45WR1YDem8ZyPUe1OfX0ivRG0DrcE7lQopJychSRyc+gHUj6VFfa/FcxQpJIMAFdxYnBx06Y7VwytunY9mM31Rl6iiajZXcssZimRQ5Gc5HTH8jWF4Ulaw8XWUyqTt34HqCjCukt0iNyvl3SNkgOnOCD27Zr3j4M/DzwlrWhXmo32npd3xufK8xmZTCAinC4IxncfzxUwXLONR9Gn+JzY2qnQnBrdW+9Fu0iDDB4U1pxxgIufpVMIYpSh52sR9cVZIdVyp59DX0DPy5KxYdCq7kb9a1LKVZ7bjG/wBu3FYAvQvEi/r0qbTNQS2u15Bhc4b+hqJRbRUaiTOhWPYfNPXoa3dLUyxecflU9Kyo1W5hBjOUbkVcsLpooDbScY6GuOreUdNztoNQld7fqX3EVwd6ciiqlrKIkKHjBorBxktEb+0jLWW54FpjZhCDqBVwDHzelUbLCTkYq+VyhOTX0r3POe5EzCTBIwaryAF8d6ecL9PSoXw7Hb170DQGE4ycn0qncwgZOO9aMbfKMnNJLtYFSKLlxdmcjrNqQ8ckeQpbkfhXJ38Kf8JXHK0LTLDbvKyhd3RGx+Rwa9B1iICMj344rCbT5Le11bX22tawWv2MLnkvLlf0BzXJmP8Au7bPocklzYmEe+n4o5II99PJIkSqo6KD0zzz716P8Po4dN0HWZtQu0t/t9u9vHblZGd1wQXwnbJIGeOvFcd4auI9Mae63BJ9q+WjqWzu6kfQY/Out0640horq/1JzMvl7Y4QxRkYjdj8cV+d6c3NfU/b3DkoKm0+m3Ut39zcwaNbNaxmbTn2s8iHGCQQ4Hpzmt3RLKaPw5Lp+oMy2+oiMRrckSeQVJ2sp7Hkbh36Vgz6vFf/AGZrW6jtMRiFod/yqoByTn7x7/0rc8S+I428LxWsV+NSuY1CNLEp4HAORjg9AD3wadNwV5t7bdn+phXhVmo04x3evdW28tzM8G+Fbq6v7u2+2tmKTynaJgQ4B/nkA4PtXpFn8PJdP1IzW+twBJE2iOWJGPHcBxj19K4jwjL4e0nWdHmk1We2W6DeYEdiEfCFQ5I4OSQa2vGU2u3NvqS3+mSpcy+VHb3d1LuaFchiFgVS2SVbLDtjpzXpYacIUU7XkvP+rHlZjRr18QqcZWi11S7267230Om1zwFpHiCztRrNokN/5Xk+Yx8ouT0BC5Xjtjpk15j438CvothLK8D3skI2wysI2kjVSCpLjaXyWIPHRcfTtPDvjq5XSrjT59We7jRmSG5a3LzumOc5KqH+YY+9jAyPWbwhf6nfXUWj67f3DG8jkNrZPsbZCVfb5jBQS2QT1GcDgAjPTDGUqjUVu/61/r0Pn6uT16KnOVko9NdV5af11Pn3S9IsL2zNy2qiG8O6Py2gB254PJPbJ7ZHUYIrN1W0sJXRIWt4BEixtcQ7sSN8wyQTjLHkngccDrXXfED4cal4ZutSv4Xgn0/zdrJESCgZhwARnHT1PPoM15exD30scrm3jkZtxfcAOc8gAnsO1az5bJOOpzU+dP4tDYtQkFwhiu47g5BJXqPxr3X9lzxM7eLNe0GUnZcQLdxbjnDIQjD8Qw/75rwK3iWHZtY+TISEbGN3TOfxrvvgZqVvoPxT02/uJSsDrPDKTzgGJiMfioqeV9DPFWlTaZ75qURj1a/QAqFuH6/Umsu/1NYQUDDI4zUHj3U7+x8V6xYRW8sqeYsiOn911DfoSRXHwtdzynzIJFHdpDjFfSUYc0FJ9j8xxkXSqSj5m4168rH5s/jVmCVtw3Z9QazbOLMgDcKOtajyIxG0cD1rRpdDhUjsfCGogFradgFI3ISa6G7CyY7H1rzeAkpuUlcdxXa6Jf8A2mJVn/1yAA+49a4q1Kz50d1CtzR5GTZkXiQ59KK02gjlClsjA7CisPax6m3spdDwmBMJvxyRVpWG0Z4qOBsxDdjOKQjIIya916kEbDLPjPtSImORn8KkVD1Ocd6cAMY6UDK5OSAuAf0p+3cOetN+XPqaepIPIxQ0UjL1WP8AdMT0FeZ+Irq4XVJrMO4tm2M0YPy5A6/rXpesZVDweTXFTaglpeTyXFj9pgkYRTME24BUcBumSM15ecK+Fte13/mfX8IRTxnM1ey/VGTbB8iB3gRWAYMx7EZGTUsOJEJ5KJj3APrj04rc0TxKbXQ9U0u00+1jgnn89JZBmRRkYXJ68Ac/X1rLe1FnFHbShju2uShVs5Hy47jg8j1r4KvQjHWLv38j9pweJnP41bt1v5mr4f0+yeB7p9TS0uYQ74IzuUDoB1JPStqz0aXWJbOTTLOSSzWUorXb7Fmy20YKnORgnGc8HB4qs1lYaP4bH9qaZqVvqrtuSYu6xqpGOm373BPXsRTW0m1Fvpwh1iFLuS5EUaW65k2kt87fMBkYTjj7x9KiMUrXW39dTSdbmu4u2tlpdfgd3qXhe906wvbJtMsfI+zKxurpEllHzbFC45DksDkZ5HSruvx33h+28nTroXDlTGltfWsYVX3KxZoyv908HaOvfOa5a21jU7HUrVfEjSygy5EshDrGMMAGZgxADENjn7p65yL+vW2qajeYt760voootqTwlefmzgnGf4m6jtj0rsnVhGL9imr/AHo8n2NR1IqvKLW9+j++/wChhx2MtjHb3NyhhWVpXWa3YN5rbhhMEjBwOOATjoagvJ9a1SeHWLBEa4tyslxcQuTISSEXzGXkfcPBweSe9dbrM2qpbaTPpl1bJeWcIgvLeO3YqJXYvuyAVJIUZyR9OTjT8KRRNp0mo63pzNdxyiQXNvGzG4HBXchByQfbJJPesoUk2ox0NJ4txh7SUU3t978+jXr6WOesdcu7WeCy1uy+x3NvGsc8krEq7tJxJIknzEkOuTkkDnGBgV/HfgPS7y687S7aS11BA7T20owS2eqdMjO4celURpkc3jCy+2XBtAjI6LcM0LH5t2dzLx1OD7YGeBXRaZq15eaPNefapjfWzIIjcYwqkHaeCepzkcYx716OFryT5Kmp5mYZdTqxU6ejtrv1+/Q+fdbjvbDUTHdcyptboFxx2A+oqzbfbbqKKTTPmuSp+UMFPXnBPHSvUfjV4RnvdJg8R21uiOrmKeKD5kDAcY9tuM+/1ryfQ5jFexxtEpcKcxkYOcH2+vFd7VpcrPkqi91pbo+vfHyLe3Vnew8G4s45j75zj9BXINbOfvCtPVRc6l4Y+Hms2hYw/wBmqlzt4GQiDn8S1SW7LIB717WFl+5iz85zWiliJGVFbAHpWpa2SM4yM9zU72wJyvBprh0GFGM9a3crnlOHKWlSOIHIBxwFqdQ8MUbqcSn5j/hWZ5pTqMmpReuzHfx+FTysXMkdrp18k1sCzc+9FcxaXYRD5YfnrgUVzSw6bOqOJaR5eJXgY9wDzxV2K6R1ypGKsXlvFNG20EGubZ5LSUo65Rs817O50xXN6nSeYOoPBoznkdPWsuxuwwCt61pBlKggVLViWmtCNB8/bP0pzN8x9qG7OOnekkfngcetAIzNVbzITntXlWvtJFq11GspELtGSvbO3r/OvVdTUCE46V5l4p41WaPKHcEYYHzemBXj57/uundfkz7Xg3/fHf8Alf6D7ay/4lnmpMrMW+ZATkLxg47811/hez0WGxd9au1iLujQ5jdiVwRzgcdBXL6PfXESPa2g/wBagRlYemGP6iuqNlbXGiwQyXjfaIpn34YcHCnIXZ93JYfeOSDwvf4fZ8y1fmfsmnIoO6Xlvb7juNY8nVfBMFvEyz6PFMrLyFLSAkFxxnncw5zUtj4KsbaK1v7RrMagirPC/nBsHHQoBnJyPU8GsrSpoRpVxaalJPLDLcGWO7KHa7lgwG0Du2Rwe9dRpWoadfv/AGrolhGptFZw00RVl+RkJ645OTz2966oxp1Gm3d2+f8AS6HjVZ1MPBwhdK79He1r+vX8jl9bktfFGgzTXQuVkidZvIDAbJW++2MbjxgY9qo+GHk0bWrd7GA39vBCzSNaq67wxIG7PLMCew6Aema6jxA6z3FpBpwhW5ihkAcwjEhYAHOzqcAnd0HBpfDV/PpFrb22wXKK7tF5gLIoI+YKvY5AOTkcHvWUuX2yU3r3NfbWwzjCOj+zfp/X5+Q6PX54Iry7i0RrW8MUiSmeJwgQFiDkc474Pv14q1qNy66DpniVj9kkhVpLfJAikXcAR8p3gDsDnqM8ZrY0nTLCeNI7sGdUdpAXJLxhm5T5RgngHLc1m+KdKstYCeHrSxnRLYsY7iTd5caHDsS+3odrDA/rXXGlOC5k/T1PMjVpTqKKi1Z6v+7a3V+hzHirWtWeGTxc6oLmT/Q4ZoUIiK4JGBuJJ4LZ5H8q534cTs/iuWw1Z5I/tTORhW+eUA4TgHA5OT7V6Z/wj0UVq8P2RdkUXlCWJl+RT8pCrnHQkcjPJ56Vw13eWGh22/R7aW21hWPkXDjlexAZhgcbvzrnq88JKUn8vzPUwtWnVoSoUY67K3Tt30X9I77wfqUUlvqGi6jFHHHdAh8tgHcoUYBPJ6dOa+ePjN4YHh7xtdx2wY2smJYm64Dc4/PNdrpV8bnxHZXVtNJHIXSR/tgTfO6twAFHAwAK6L436eureGtP1woPNUJbycYGRxgfiK9XCVFiIOL3R8pneE+o141Y7S39Ta+F179t/Z3jkjJM+kzSW+O3Mqtgjv8AK4qfS7yC6RWX91LjlG9fY96xP2diZ/hT43sB/wAsp2nA+sQ/rHWrpkCTWkfy9R1r2sA702uzPzbP4ctdNLf/ADOgiyKseWrgcDNY8bzW3BJljAxtPX8607W5jmH7tgT6HqK6mjxU1LQmFohH3elOg05ZTyMCpomIxn0q5CSoyBmocmhezTeolvaJGmEAAoqwp4zg0Vk5MfKjxlZ3ZeDlWHY1W1GItbHeQwHqOlTS2MkEpaIEqOxp12A8HKnGOa9lHUrJ3RzccxiO05xnNbWn3oZcZ4xjmse4ttpZkOR6VBDMUcqMhu/tVNXOpxUlodQSXPX5Kn3ZTgcVn6fdLJHsflvWpkmEMu1iduahnPyu9inqxxEcHivLNQMb6487OxIZACBnPA/KvVNViFwoSLl5GAX6mvMlgkGtNDEBsXEjOOvAB4NeDn87UIw87/cfd8FUeavKo+1vmdR4Ws7O9uUSOaZSzM00bcF228FT+Jzmuk1DRW1mzaSEulxHdsTMu6QIg9VA+RQec5Oc+1c/okKzoJNQlNtBEzeVtf52J4LYA59Papb/AFW5tNUtLuyvzcszKwUqMqwwQQD0J9xXxM5xTdz9UpwqzklF2aR3OoWAi02HQYbyJPssqNIjBxvP3jtJAI+ZvTqDXV6jrEdpZaZGtpK2nXcQgkltmSRvOKrtxk8nduBB4+vfhvB2jXSRGfWbw22oRq5WCa3DryPlyRkg5PTHFb8w027n0+3hktVkXH2lYYyyMWTDcEYzyw5xy3Ga6qVTlTezeh5lelCUlGV2ldvR7tb/AOW5m6ZbwQ6tcq2/bDv3T3MIQIzMMOmT0Ow9MfhWvousy2VjbaYbWy1SxLPKJZFRlz6Hcy7cH65qxZXD6V9tgu9JtUtYi8tuJZ1WRoyCv3dvOQADgjr9K5W20SxufDMsaQSktcAQt5hfPGWPKqD0x171S5oPR66/8MN+zr39ptpZ6Pvro1axrXWsL4f1xxDaXTxtKD9qt38xTyG2n+EkAjI7Yx61y3iHVrjUvFCW125ksw6IEciNSDguxHQ//W4Fd1DaadYyyjSopykwMEtxJNAZEYYVkCOSz9Afrxjmq1loulDVLi/114otRhdRHEj7RtxyDtJyQD6jHGazqUptpJ6X+Q6OIo0pe0cW3a1+r+XT7yHQ7rX9X0EPK0cEZmZ/tEzIZXVV2gbeTgsMZxjg85rC8XXt/KsWnm0ijnuJUa1ntL4skUx3B0lMh+TK4+Ukbdv1rsppLTTLp9S0+1sdV2WxC2cMm3aOcPhQcpjGR3LHntXEhtQ166MWprZX0isGhUgCVBnLBME7uB3x0q22o8m7ZOHlzzdVRUYr+tr6+d7K2xyGhedbx28v7ySGK4WZj5o2bhwMjPXGRmvW5bSTxp8PbrT7aaGO4Z0lgCNwCrKGBA78nnvkVxWo6bp6WF5BHZzC4dCYn+zeZubAwFOQFyRjcM46Y5OE8CanfeGb1Li7tJkjXIIZG5+UgDgf5xW2Cqyo1VCS0YZ1hI5hhpTp6Sjql3L37LGpJba54j0K84k1Py1VCehRJi4rqdAlEaG0lGHiZkOevBxXDaFE+iftIeHp1VY7XUppJoth+UrKjqB+DMRXe6tAYfGGqpENoF1IfzbP9a+lwLSlOH9f1qfjnEMHaFR/1/Vjc8hWBP8ASmS6cjkFH2sOQRwRUMck0jhBuUE1vQxoYCHIz09812NuJ83yqRlwfaLYFZMzx/wkdR/jWlbTg8qT9D1FMNqwOYmIPv0qIwSA7inzeq0m0xaxNSN+DjOOoorPSR0HINFQ6Yc6PP7ltsTMTzVePa8a559eOtPmDzAAHjPrT5EWIZ4AHpXqnSildWCum9AAw7ViX1okcoYjax4rpDKc5HI7c1HNAkqksBk007Fxk4mAmll0Dwtg+xqN4b2FjkF8eprWUNbAkH5R2zTbJmuL4bm+T0p3NYzZx+p6m2HVt0cq5PJxg47GuUjuftDQQW8MUITKGUA7pCx6sc9hxXonjWytjbNOf3bRncWUc9P/ANVcjpENpcadsAElyZhtRWCHHdmOOg/pXy3ENRpRSP0ngmMJ80noi/YaPPFGJnLXVsFDM0Rb5SexP9Oa6zw9YPaThp4UaaRY1tJJMsd5AIYnH+7yeBWfFrWhabNb2OrQyNZLAN8VuvmfvMZySWBPrx/Ku40bWbS7udKj0eWOKa301BM8wb945K4QDcdwwvBHNfJ04JvVn6DXrtRaUfn5dLm2dFu9JtJVzJePDIdy3N2jRLxuCk7Sz4GMfLjoCeK52waYXN7LC9uqWOFVChUEAHLAAcNhS3JHPSqV9PeRaxPby2TWepO4draD5mXcQoBbOBkkdj1HrWlIr6Vd3FrqQ860RS8scU5EpB6jLH5yN+AOPoO3RKa6KyR56pyjH3mm5K/5X6v5epkiLUPFDgs11LIGBZyvQ5HAPTknp+lb9lp81neRCa+iubuQMrTPLK0U+OcqCOCBtBz6celavhq3+0G9tNOiWysQSq7yk8u45AIY7gPlGDg+4zSt4cEKw+XfyIZtyidYw4yMHlcgDgYyCOv4VrSpSSUkr3Ma2Kg26TfKlsvl1t+SOi0WOK6T55zLqMAYcoDs55B6g8gDPtTbrSrFbEzTWYmujyXRMurE9fwPP4VchnjcJDavsuIsI8jg/vDjnB+tVE1qVdUfTJV8x1bBYZwe45H0616U3BRSfXQ+ej7VzcodNbbaf5GHHFqwheayngJZy7LLa4DDO0gNgY4HQ8ZGT1rYS3tnnS5tNPRJVUgvEqoUyDkqenAznHOD0roopoXiBGGZTnDrxgcdKydQuHlhWPRJPNuJAZXiMpw+Bk4xyCe2c1ko8mqlcv6y6z5eW34ffaxhXmj3NhpMht5Wv7xm8xRPtdTt7YGMdeo54FZGowT3GlvNfWCJeKEiCQIGXacNkZ6EdP8A9dZ134r1HSNWX7fYzJYXGUXcS8qEKM8sFP6dK17bWU1m1lXT5WWZQrbVJDKvH3uRzn0NKNSFTSOnkehOlWpJSmk763/TTQ5fS9Ma0t9JutdR59S0W9iubSeNgdsQljaRG7n5UbGOPmrvvEcQg8eakjAbZtsq/Qog/mDXmNxd20V1HcWlzcZhkC3KsSCjo3OB0Ir2HxMkdxeWGojkyWcZ3euSTXoZZUvJ39PysfG8Y4ZRtNLfX/MqwQpvyByKuZ2qDgYqlayqkTNIw5HFO89XHB4WvWep+f6I1YipUHgH+dMbmZsYAqpBdqpGTnFEl0m8ndjNTyu4pSVi4mMcn9KKoC9QcKTiinyMy50eezlYo1C8OP51RupW3Bg3y+9WtTTLo6ZGW7VRuAUbA5B56V6yOqI5ZgwDHt2p4kZycYxiq4YBMkYp0bYYEng/rTsVYY+DlSQT/KmQqIW3Kce9T3VqMeZHxWbdStGHA596W5pDXQ57xreG4s5IEblmwfpXMaLJbWimSeGSSXOVB4Uj36HqKn8VSvujkUjiYAjvz6flTm1Rb60NuYQ06kFpM/eUE4GPxNfEcQ1eavZdEfsfBVBQwvqzd01tC1K6jfUVukY8EREHgKeFBOQOnr3rovD97HZyXc9hpjGyNyUgFw3nME3HaAuOAoHzNkcsPw5DQtElvFuLiC5tbaOFA0huZBGOSAAB1bkjoK3bTQJtavC8l2JFjxLKkJXg9mGOMEc+tfOxlLR2PtK0IWalLTqrvQ6yRLWWCS98zztQmPDRsEOTyDkc4BHQDHp6UuklJrmceI5IPLWNxHJHEXYSAELnby/4j8q0ZI4tDi07T9LFyW3Ryy3d4pEeWOHbeD2zjYOQATnis/Qpl0828UMJk1CUus0yHDLuJwR6D5sck8ccV1Sik1zHjxk5QlyfLo7fodFDfae2o2UOj3VxNYxAh4XUIQxG3ePl9CPfGaqeInTS7Pz7RJJ7UkIIyAwDZyQc9PXpWrJ4e08W9ilwt9FLKyxhpH2EOcDjAyO/XNS2mn2ljHLFcfaFklw/+lfdUg46g56Efn7Vu6VSSvKy/Q4VXoxkpRu/Lvr/AFqW/Ba390iXm6U2pAVIrhVLK3BLAdhx35qt4ja1g11VbSbyHUxiSG4jk+VwpJJcfgfzq7o3iWzsLl7C5a1tCZmSONphuIBUAkHkbs5HJ79Kta4g1WKRbcrHeAuqSIAxUHqOfUZH411pRnSSjK7X9dTzXOcMU51I2i9umnnbdd9zHW6W/wDJ1GDVDbb0DZklCRsOpAY/KD9fQ1D4l1vw5pxtbkauLYA7hNaYdj3IIHGeBgHAHOMVwPh6/uNFv7jw5fIZE85wRgEksBxxk8jPOMc1teKvDZaysNJ0+0eWeUeY6kiMEbGAGC2D83O4nIAPWuSNSbg3GOv6npywdOnWjGcny9LW1jbqUvEXjTSdZthFpcl1cyRuZ/PuogcELtIIBJA2k85A49qyPD19Y32uiZpZ7KSKLBkPEbHGCRnoD1HrXH+KtJvdBlvLO1uXWK6aO3BSDm5UqWKgNg8MEz06jrXo3grRtM8MeB7PVvEhne5uGzHCdqKingcE8t1JyeM4962wlKpWqLm+fkZY/F4fA0XGDb7ed/61MDXr6DTdFuLnUJLyNp0LQxcYnCn7xP49/SvXPCUr3/wg8KX7Nuf7Mkbn/dDr/MCvmz4m+KJvENxPwIraIeWkYI6Ajt+XSvoT4I3a6n8BLOPILWTyRH8JN38nr16MY06iUNlY+FzivVxWHc6u7v8ALQnjYFupzVnepyEG7Ax+NUmQq2R1qxC+BjH5V7Vj88v0HiNzzyM0FSGxjj3qzGcbfcVIFBJJ5ouS4lVYdwyCaK0lh3jg4Aoo5iOQ86lxwPU4qhdZTCDpVt+ZsYOFNR6ggaPcoya9FHoRKknEShhkk1Gpx8uKVjvVTzlaCc7Qeoplot28wMZGMZPSsnXUWOOSRDwB0q3vADZzj1rn/Ed+sVhOepA/Opb5dTajBymkjlIdTgW7ubW65tLpwJFUANuAIUgn03Gtzw74W1a2s77UrOG2v9NEbQynOW2kDJX0IzwfavMp5GeTe77VVgzHbgnnPFelfCHxdd2V7Y2KmQeZMwO5yBKD/CR35I/+tXxuKhCvUbn1P0jLsZVwMF7PVdUa+lT3UdhJ/Z6Onknyp7aB/wB/IhwVJOOgK88dvetT+wNV0OcRaZYTJFcJ5ThdshRxgHzDnoM8sAAM1neOr6XRPF8upaaksL3QDSLt2/PjBw3pnPscVm6nrGoapptmNOjkiV90TrbIyGY8DLAdc5xxjOOa+frRjCUoPWx9/h6k8RGFWNkpLW/9dGdJqNzBe68kfk3lxdRoAXiHlvgHGxgxwWJOTg4wfY1upqNrpmo2VpIk7alIMykhY2iATcMjJOMEc+g7Z4x9L0m7tdMEKm0N35ZmYyAL5WOSrK+MNgdPUirek3OhTwKhtIkuogHW/d1UqR068+n5U4W5tdJMxrOLVldpaafn6eS3PQpNPub+zjlu7tWMbKFG4IwwDwD3+9361xnxRvZNOmxbXF007IgkKsGl6kjJPGOvaqPj7U5E06xWymuLZrbB87HXjBJ9zgfkahsdSh1C6uJNXs3mhVBJBcruQMQQrIWGDx5mcA+lXUrRnenH7zjwmEqU1HET1Wvupf0vMqeH57bVr29bWIWLnKLct8skQ6EgjgkHJz249a6rVNeh0XSriPw7aLMu4GFIWLlD8uTJjOc9Qcjv1xVuPwbp+ptEbdrO2tMIY0WR8xHaCwDEcj5unPI61W8faTcaNoktxo9vasEU/aXjuDFLJFkAbk4DjmQfLnjI69dI0alOm5L7+pFTFYfEV4Qd9fsvRf1/XUs6vJN/Zv8Aa91psUrAB3e1cLNEu3kkNjkdD09O1R+NHtLjQidGZUMYV5DK/wAy5OC27qBjr2qhpNpba1FbT2UQL3CHzLgagYwRg5WSMg4GMAso6YHqap3d7dBkEMJin0i2mikkeIus6qFXb0KleGIzxzzgGtKrc43fX+tzKlD94uXeL26eStd9rfPYw/BoXVjLpV0ttKz3MRSc/Mod8L8zdeAowM9c1D8fS9hpWneHiw2WiCTzFPytliMDv610/wAO9P8A7RuLjWQI7Y2kO5bdVXYzjcFJOeMbiefbpXmfxc1OTVvFMgH7wwr5TFeVDA8gEe9ejgYcuHu+p4uf11UxihDZateZxNzYM9sx82MM+MFlxjpx+fpXu/7LupGTwp4i0Z3LOhuZwCefuRLn8zXll1o00mmWssk1tb26qdyGXEjbsYwO/bp0rp/2WrhdP+K15pbSb4rqyngXngsGRv5RmumadKSZ89VtWotHr7lZEDpyGGRTkOKydFnwrWkv34CYzk91JH9K1hjIGK91q2h+czVnYtRHKjNWYzkY61UjxtGc8dqtwgA4qWItRP8ALxRTY2UL2opAeazIQwZZCCTzUF1KyqdvH8qnYHzTuPB6VQvmIUkH5favTR2R1IYpQwbI57EU5ck9etVkOI9x656U4swGR+QNUa2H+YEjbd0rz7xheFUkCOAu7kY7c12F5dbLdt/BIrzHXp2upmCt8p4xx781xY6p7Ok11Z6+VUOerd9DPubaUbpJI5In3H7ykZPPHNXdKFxDqFncCRh5TbiTyV59adpiSzuQoVkCgfe6/SrdxbybHU5VeMED9K+ZlG7ufXRelmei+K7241Pw1oeqIfPW3X7G2zP7s4JBOMZJ55rO0Bg9k88ls0kEAwocfIZRyB6dO3TnmpvhHq9mXuvD+tyLb20n71XcdxyD+X4c10firStU8wx2un50JYi/2mELycfOxAGRkc4OfrXn43Byqfvo6915n1eR5lBU1hJaW2d+n+Z5jq90886ySKyTMu6aRnJaViSd3t1AwOOBUyWV2BG+tRX1sssQa1ee3cJOTt2gMcAAgg557etduy6JfWNhBcWMVtaGTyw8x2iP72C0mNxz6ZCgnOOKraDa6lFPeaXNcLNpEsq/O12skSRRvuUKpzt3EJjgHj61wRw8fta/11PdrYmqv4atbv2v0/y+46Pw09vpW63tLpZJbqKOFri7g3pBOoYsEkI4yM4GPxrTbwzdXF4P7Knh1gTKQ8cWYVGMfem56YHy/wC0PWq/i6SCW3uryzsbS0W0tiyB+srltvy5AOcHOF4GOetO8M+KNS8MxRro9mxs5c5F9KsfzfNlsjg9FGeOoBHANdDjCL9nJaL1/Lz8zzLV5Qdal8b6O2vq/JW2ZJN4hktbCG9uYJxuxAyyRrGsjhRxkEAJwQSMeuBgE0NK1mdjfz30zrHeMHiuTLuQMq7tu0cdSANwK5bjuax9Uv8AUtXjtktbLSxZC4k8tFVN3zbdyMw+8Pc8nnJqutncf8JJa+Wlu9uXigEcMISN1GEwSeN2cgknk1k51ZNOF2johhaMYPnsnr17PRf1odF4GttQtbO41CC9i0q1PmKZJYFd1JYcq20uAR8vpzXX61p99BoIjtZLaeF3E9yrrt8yIY/djAA7kk8ngVYsdJ1W1uYvO0ozWSrt/eyIrtxnGz5hjd79B0FWtaubrw54Svby/MMuoMpMMaISRkDCAZOefwr08PhOWPLK+x8vmGZxdRVIWeu2n49dPM5P4q31hoejQ6VpCiKa7zHcSRLguh525A6kZH0ryM2QitwApKuSVB5wM9PrW3Bd3+t6lHPrlusc7nZFGgAGcYDAdupzn0q1NpzTX727I8cUA+aVUHLememeRXqU43sfN1JtybbucxrdpPb2+1bcM8kY2vIoygHUgn8f0rF+EF5Jo/xa8L3LZVZL1IffEmY+f++q63VbpdRvo5DcLGsGIzk4JBOMjIx+AIrlYrW9tvFenao4dIbe+gfcwAztkU/XFY4izd10NaSfI4vqj13V9RGm/FDxHpczbZIrgyqDxlJP3gx9A611dpOJFznpzXmP7TqT+H/iVb63bLhrrIOc4cJFCuK1vA3iODV7TzIpNwAAYZztOBx+telgsQq8OV/FH8u58bnGXyoSWIgvdl+DPSbeQYyeRipo+uemelZtnMHRcEdOK0YXHAJ710tHi3LsSqV60UoxsBGBRUgeYzyYYc96ztQwejEirVwDwSec1UmG9T3r1EdsSoX5Yg8U3zdqn3oYAHAHf1qreXCW8TkkZ5zntxTZ0RV9EY/iPUEt7YneAEUk15/HqFs7OZyoz91VBPOP/wBdS+IdUbULjMAD24O0tuwG5FYEKRmXc8yKd+NhJHH1r53MMX7SfLHZH1mX4T2VO8t2egaSIoWh8tQGkG5mHUAckde9ad5vu4mjSLYCc5H+H51z/hnXE064UQXETuVKZYHAx0JGOfpXVaNqa3zmNnBld1G88HHfnHPT9a82VRPqerRpu+1zltU0+ezkhlSYxyEn5hkcY6H1r2L4R+L01O2k0rW4450jjDoXAGBnaevUH+lYN7pNxeFVgkXP3UC4BOBz+grE17w5PppguLhGhjZVJlDCPB5yqg9Tx07461UZODc47Gk4W92+v5HreseEFvtIjgsb+6ltVYEQs4dGxnnGOO3PtVXQPAc1jc+bJcL9pIjZYTI0kW1SC6yjA3DHGMjGTXJ+FPEep6Xo9u91JHIm7zt8rAbuQcEEjrjryK6Ox8XWloinU/NguJYsxOWO5gQCCWAweCpDLnj1zW3saE2pyWti/wC18fSg6UXdX7bjtX8PataXdna6bY311auG2szrOkZA7Y2jaQACH3cd81fXwjq/iC3a21K2gtkmAfzdzPsIP3WAAz93PHHI961dE8VvYxfZZ9RhuwQzeYwYlQF78eo69Kt6l41igiXZdx7HP3wpIUjsT71nLAUpN66PpoX/AG/i0kow1XWzGeGfhtp3h2KWWU2t1PMgGbmEN5TdTsGeO3Jz0HvnZbUNMtrhNqpJKx3TMScBhzkjpknP41xEXi+WazuDalLhY5jHvOfQ8kn88dcGub1LVdSvb3T5JI4lSGQ+YSM5IYHnnkf/AKq3p0qVCFoHl4jEYzGVHOtJ6noXirxjN9mlTRZ41uQcgn5vlGcnBPrXmk9lrWva5C2tajPJImBFExAyhJG5VHTr0xXVHTVtbd3hjlnnG5zJNGFY9SVwRgDI4qv4S0+9h1M3Wp25C7txd2LbUPcAZ5P9K2cYu2hyRi4J2ZPY6Da28Qnc5khJZSx3OffjAGKp+IpGmspHSLMcWBvbAycgEc9sYrtNqyeSkcTLHywT5RnGD6E49ag17S49RtEilIhjJHOcAN1JAI79Mn8AKUp6NIqlFJpyPFtUh0/Tb1R9ljnvGj8xVkO/bkZzjp0P6UXOrx3EGUnJnMPlqphztIHARui9PTjmu61fwXLJqcJW2mMcrOrzsVTygvAIHU5H0rjr3wqNOuJnuxKsJkKq5+Un3x+B4rgqOWp6dOMHbU639qO0j1nwh4S1yLaRKrEuOQfMjRwc/wDAK8I+HmqSaRr8cAkHkXB2sD03dq938W61ZTfBfR9FkWc3+nuigbDt2KHQYfp90ivCPsK219FLtU7ZBIMdxnmlhanLXjOPf8DmqYfnwsqNRdz6G0a6ElrFIG5K5xXQWc+7GevSvOPDFyTp0DA7UKAgHtntXbaXIGAO7PrX084n5jUi4Tcex08LgryaKrRyDb2X2orGzHc83BzLtyCB61HckhegoY7XU4I9KqapOqxcEZFekd8Y3ZBLMkdu8jnbtBPNeTeMvEH23UJLWCSRLeNiGaM/6w9CPp1rR+IPiYSobCykBVl/elfT0rhbFENzG027y9wZtvXGecV4WZ4+z9hTfq/0Pp8qy/lXtqi16I1tOjH9ltIflkbIjPPAHp79R+VUI7IpdiGcgHbvbHO0YyfyArrtKkW8htgIhkykRJgbVG7JLA8AY5596orBayeIIksUlKSHYSRgseRk88AnBJ7ZPFeROzS1PdpRld3MaxZ9+IlTG7byPXNd5pbXG9ootojjIZgkYXIPr3/Wrem+Ho5bsxJEPMeJ5Y41IC4ADEsT90bcn15A9a2NC0opaiZtqqrZwh3YPvjtXNODielhrSZv+G3cWxeV5FGMAbyBjjt3rpdO8S+VtgubMSqRhZASwZunQnisrSQTGV2L5Y+YFgTk+3GO9aEEM0Nz5RtgiFcqcdRnBP8AL/Oa0oSmrOJvXpU5JqSOyt737TmZMGFht2OPeobmxsbh1K2IiuACu/ycbwcDbuAJx04rJtbWWJ5N7c43Kd+0ZIHYcfhWobuRdPVJArTxrz0Ab2HuB3r0lVbVmjyJUIp3iZ+p+FtPvNPSS28v9xJnjahUYHGQATj35rlb3S3ivSLueeW3ADRvGpbfwRyAR0Oe9dfNf71/es7AvjbG3Cqe+QM56UX72Tug+baSchjwOO/b9a5px53eOjOmHNDSWqOf8iDTl2YjjDN92JcKc559/wAeeaqa7CbiPfbzBlQYVw5TPTOMg81s3iafdXp8j90igMflK4Y/X8elRNamKV/mRiTk4O7aCTg/jQ5u1m9B+yi7PqZa6nNZRRx27T3Fuihfn6ZPXp15P5VuLqES20MZUbZUjO5OHwemePb9ay5bCeSebZbnbt6KSV28cemfaprOG6/tOF3DKkfZlIyOmfrzVRm1sc9SjE6jTNWzPDvkWObkkNnJGcdcdMfzqzqbyz3jtBMxdkUbUXqOvB/z0qlZ6O9zKrvho0JYbzllPH6cVuQ2TxxbVG0Y6jOT+NapSluckuSGxyyXN1p8Fxa3EtvbxPh2lm3yyEZJIAOQB2HrVC30K3YSX87GWU5YFjk7hx0zgdDxit3VVuLKYyH51flwMdM8DB7c1j3V1POxd4gI9v7pACAp7f1rkqONN6ndRhKorrqVNU0mGdRG0p3SfN8wyMY/wNeV6po7WVzLGGTLMQoYe/avU1t5dwadNxPAXBP6muY162t2llEaFn2OV4JIYZxwPrXNCpaotDqnRSpvW+hneDZzFFLaXHKoxI/nXd2LtAQpJYdQfWuJ8KW7DzjMuHY/xDBGCRXcCH5I2gIPGWUnv7V9jB3hH0PyTNUo4uaj3NdnMmGTehxg7Rwfeiqkc5CDC/nRRY87nZyFzcrFCzNtG0V47438U/b821kxCE/vHB64J4FaXjrxWMS2NhM3mFisjL0Ax0H515yFJNedmeYcqdGk/V/ofe5TltrVqi9BmMmrVtC0pwqk45OPSmRR5PStjR4j5jLkruwDj0NfNtn1VGjd3Y+C3dYsElZBjC47Vu6BosysZPnWJso7oDwOCQT9OTTbO0kETeSmXY8lj+Wf1rttNtp0iDSLhY13FGXqfXP44oS6nYodCzoGivZrNHJJHm8xCzkjhcnI3ejEKfoK6SzsdQspJYLdbdvLXLlHDK/GcY69OOnUVnpuwXt2BEgCsA3GOBW9bAXSwefI6OhyrqSpUDOR1PXNawcZGjg4CafqEwEiXLmH5uSF+7jtWlDcXITa0qksBs3kcg9PpVW5hY5+zlGwQSzDk9ueOaJrFrryzIcIwyCowSfw+tbxvayMqjjux0UUzTPdLcMARs8luR9Qe9KDMZFErMxckKincevJxWvY2u+ySIo64J+ZueRU6aDM7oWClBzkL+ffnvW6pSZyyxEV1Mu1Vo3/AHTISzEBiMfUc+1akcMEb8IFLjO5vm5/D6Vc07SXhLqhXa3XcvNa0NkuG3RDHoFzitIUmtznqYhM5iaANOGMICYxtOQOv/66mfShPIk0ZIZQSFY5HTp/n1rrY9NhcEuoDZpTp23kAHIxVcib1MXiNLRMDTbQ286+WqKQM4AOPyq3JaZkd0G8seBj68Vr2tqI5PnJLDParyQL/dGfajktoZSq63MqwiaMfdYY+6G7Vca4/dklGLJwfl681fW2+bkdfQVILcAHjFJt9zFyi90c3PC7QmTy8F8lxjl/SqD2LAoqxmMgg4Heuvmt2K4UqPqM1WuLdhkgj8ucVhUSSOqlWscffxIyOPK+90GDnNefa/ANPgaeZ3MhR8AdRx/9c167dRxRzlJYwqDJ3H1x/k15h8SLmzg0q4mLgsqMFXvn0Fee4c0731OxYj3eW2jPJLrx2dPvntorR5Cv3mZ8c/THpitC28dX8v8AqLVFP++TWBZaVBfTy3MyHdIxbn0rrNE0S2SMsy/T6V9VhoV+RKcj5DH08Dzubhd/MjPjLxCTlPJVfQpn+dFby6LAw4C/lRXR7F/zHAquEX/LpfcfPzqZZCxJLE5JPertjp7XL4j7dW7Vdg0oTrnJT1NdRpWgojlY2cR4wWYYzXxcp31P0ijQMW00JPPPmZ2oM7e7E1uWmheXbNKEOGYDb3QDP+Ire06zihnilfb/AHRvOQDnuP8APWuq0KBporkJBG7MSVYHaDgkH8Pu0QXtNEdTgqfvM5q0077PKsbRtKFJBbbtyOccfr+NdbbQq0S7YvkwN4fHbrj8qksLGGNJCzSMVwQG+bqOR/Sp7aPKxLFnnqMdj2/lWtODuOdrehRaCH7UyomAcDcD149ParUVvuRlVpDs9uCKlaBIrony2LqR944ro9NSCRCcrtwcso4NdMMPdu5jUr8qVjP0u0ZsmXc0KqO+D9PzroNHhSOI5XdgZXjgUWtrAG+RtwbqCOKtT3VvayrAhUOSMDGa6acFTVzhq1PaOxbt0YXKlkwcc46GtWGEkfNhSOwFQwsHhEmFbsc1MLsIoA4OePc11dDy5vWyGm2cSAjGN2T6/WrcSEklR8v0xUsEolUscelSGUAYxWepLn0IwhOAATTmXyyARx3oEzKcLz7U95lZcMozSdybu5IYty5Uc+tTxwgcnrVZblFGC65HbNSSXiRgFmCjHes3IiSl0LuAO1J8vesK61ZVztdSB065NZ0+tueDI0a9QwOP1xWDqW2RUaDe7OpnmjiQs2B3weM1hahq8UVwVXA5ABPcf5zXD+IvF9rYM/23Uoohg4Xdyf69+1eVeIviUomkTRrYysDxcSucZ56L9TWLjWrO0NEbwjCnrI9f8XeMYbHTpJp2gjVTj5nHPbivAvEWvXHiS8RcFLVCeM5L88E/4VkTT6prlyG1G4mmGd2GPygn0FdBpWkbXBYEV6mByzll7SpqzhxePjTi4xDTLX5VUKdoFdNDCqoApplvbLCgCgZqdTjqK91K2h8xWrOo7lmFti4J/SimAggZxRRYwOW0fQUhmzJhSuCB098111jpcMmBz5nGAehP/wCvFSWOhXj3ymZkAbGcGuv0rSE+1FHfsTgD+tfEU6Epbo/XnWhBe6zFHhFVlKtcKJnX5Bxgkf8A1qS00yW1k8tlUyLJs3Djbk9f0zXodppSy2kbEhZI2JDY6U19LPmO4YSOw2ksOPY16lPDQjZrQ8ypi5O6bOQ03Sme0d5NgO85NTpY7GLxbQQclSa2pLeZLsxn/UBTubjrg8/yqG1tw83nJu2tknPcY/8A1flVOkoWVhRxLnrczINIljuJZdu53xtyc9etWUtDaRbNxLE55HT/ADitSGRkkyHLKexJ4FYd7qDBpJpQenQHgValFIznKUti9aytZAyfNKSTyB92mQ2ryzPeMVLMcEAf57AVgPrSoAwDnngZ45rGufFt95H2e1cRKpwSByc03Zo5nNp6bnoceoxrB5bMEZW4G7+dR/2tbh9zE5U9P8K8pk1uXLb5GPq55NZl94ytrJcbpN59FJJNJRa6kuSZ7afEdvbhQWbJ5qdPFlrgYYDPvXzhc+Pb+cgWcCgespz+gqtca94gugGV4IvQxqM/rWqoznsmYyq04/EfSsniReQp7FuPSsubxZAuc3CgjP3jgfrXzhJb6vc75J7+fvnEpAH4Cj/hG7uRQZJmbP8AefNP6jUkQ8bRj1PeL34h6dbA+dfwqwx0cGudu/ixppUlHmZg2cAEkj+Qry2HwtLkbivT1rRg8LqGG801lbfxMylmtKOx0+pfF2UuW02wJfHBlfpx6CuQ1fxh4i12TLXEkEe4sFhJXH49a24vDUCDJwatQ6ZDB8qqK6YZdTW5xzzdfZRxtvo1zdsJJndmPUsck/nW9Z+HEjVS4ya6OGJUUYA5PpVjaccV1wowhsjzq2Pqz6mfa2MMGCAOnpVxVAHBpTER0ziohnJBrQ43Jy1ZPkgAdvrT1BI61EMjHpipUXIyelIhkyLxRQM4opkn/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Large venous ulcer on the medial ankle in a patient with chronic venous stasis. The ulcer is shallow and red-based with irregular borders.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Patrick C Alguire, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_14_13536=[""].join("\n");
var outline_f13_14_13536=null;
var title_f13_14_13537="CT scan signs of CVT";
var content_f13_14_13537=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F59194&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F59194&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 512px\">",
"   <div class=\"ttl\">",
"    CT scan signs of CVT",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 492px; height: 204px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Noncontrast head CT shows a hyperdense thrombosed cortical vein (arrow); B) Noncontrast head CT shows a hyperdensity in the torculae (black arrow) and the straight sinus (white arrow), a direct sign of dural sinus thrombosis (the dense triangle sign); C) Head CT shows non-filling of the confluent sinus after contrast injection (the empty delta sign).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_14_13537=[""].join("\n");
var outline_f13_14_13537=null;
var title_f13_14_13538="Patient information: Tremor (The Basics)";
var content_f13_14_13538=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?13/40/13954\">",
"         Patient information: Parkinson disease (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?5/4/5188\">",
"         Patient information: Parkinson disease symptoms and diagnosis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/50/28449\">",
"         Patient information: Parkinson disease treatment options &mdash; education, support, and therapy (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?29/63/30708\">",
"         Patient information: Parkinson disease treatment options &mdash; medications (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/6/34913\">",
"         Patient information: Tremor (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Tremor (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/tremor-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H32695766\">",
"      <span class=\"h1\">",
"       What is tremor?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Tremor is the medical term for trembling or shaking. A person with tremor has a body part that shakes, and the person cannot control the shaking. Most often this shaking affects the hands or the head, but other body parts can be affected, too. The tremor can be a problem on its own, or it can be caused by another health problem.",
"     </p>",
"     <p>",
"      There are several different types of tremor. They all fall into 1 of 3 main groups:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Resting tremors &mdash; Resting tremors happen while you are sitting or lying down and relaxed. People who have a resting tremor can usually stop the tremor by making a point of moving the part of their body that shakes. &nbsp;",
"       </li>",
"       <li>",
"        Postural tremors &mdash; Postural tremors happen when you try to hold a body part still in a position other than its resting position. If you have a postural tremor, your arms might shake if you hold them out in front of you.",
"       </li>",
"       <li>",
"        Action tremors &mdash; Action tremors happen when you move on purpose.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H32695773\">",
"      <span class=\"h1\">",
"       What are the most common causes of resting tremor?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The most common cause of resting tremor is Parkinson disease. If that is the cause of your tremor, your doctor or nurse will probably focus on treating your Parkinson disease. This will hopefully help reduce your tremor.",
"     </p>",
"     <p>",
"      Other problems that can cause resting tremors include diseases that damage parts of the brain, and a rare condition called Wilson disease, which causes copper to build up in the body.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H32695780\">",
"      <span class=\"h1\">",
"       What are most common causes of postural and action tremors?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The most common cause is something called a &ldquo;physiologic&rdquo; tremor. Everyone, even people who are healthy, has a little bit of shaking of the hands. This is what doctors refer to as &ldquo;physiologic tremor.&rdquo; It is normal, and you don't usually notice it, because it is very mild. But in some cases this &ldquo;physiologic&rdquo; or normal tremor can become exaggerated. This can happen:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        If you take certain medicines, such as those used to treat depression, or asthma and other breathing problems",
"       </li>",
"       <li>",
"        If you drink coffee, smoke cigarettes, or take drugs called &ldquo;stimulants,&rdquo; which rev you up",
"       </li>",
"       <li>",
"        If you are anxious, excited, or afraid",
"       </li>",
"       <li>",
"        If your muscles are very tired, for example because you just worked out",
"       </li>",
"       <li>",
"        As the effects of alcohol or other drugs are wearing off",
"       </li>",
"       <li>",
"        If you have an overactive thyroid gland",
"       </li>",
"       <li>",
"        If you have a fever",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If your tremor is caused by 1 of the problems listed above, the tremor should go away as soon as the problem goes away. Of course, if your tremor is caused by a medicine, you might not be able to stop taking it. But it might be possible to switch medicines or to lower the dose.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H32695787\">",
"      <span class=\"h1\">",
"       What is essential tremor?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Essential tremor is the medical term used to describe tremors that do not seem to be physiologic or linked to any health problem. Doctors do not understand what causes essential tremor, but they do know that it can be passed on in families.",
"     </p>",
"     <p>",
"      People who have essential tremor usually shake when they try to hold their arms out straight. They also tend to shake when they move their hands with a goal in mind. For instance, their hands might shake when they try to write, drink from a glass, or touch their nose with their finger.",
"     </p>",
"     <p>",
"      Essential tremor sometimes even affects the head. This makes it look as though the person is nodding their head \"yes-yes\" or shaking their head \"no-no.\"",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H32695794\">",
"      <span class=\"h1\">",
"       Is there a test to find out the cause of tremor?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No there is no test. But your doctor or nurse can learn about a lot about your tremor just by asking you questions and watching you move. Your doctor or nurse might send you for a brain scan or blood tests to make sure your tremor is not caused by something serious. But it's likely that he or she will be able to tell what's wrong just by doing an exam.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H32695801\">",
"      <span class=\"h1\">",
"       How is tremor treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If a tremor is caused by another medical problem, treating that problem &ndash; if it can be treated&mdash;sometimes helps reduce the tremor, too. For example, people whose tremor is caused by high thyroid hormone levels often stop shaking when their hormone levels go back to normal.",
"     </p>",
"     <p>",
"      Even when no other medical problems are involved, there are treatments that can help. There are a few medicines that can reduce a person's tremor. If the medicines are not effective enough and the tremor is severe, it is even possible to have a device implanted in the brain that can help control tremor.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H32695898\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/40/13954?source=see_link\">",
"       Patient information: Parkinson disease (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/6/34913?source=see_link\">",
"       Patient information: Tremor (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?5/4/5188?source=see_link\">",
"       Patient information: Parkinson disease symptoms and diagnosis (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/50/28449?source=see_link\">",
"       Patient information: Parkinson disease treatment options &mdash; education, support, and therapy (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?29/63/30708?source=see_link\">",
"       Patient information: Parkinson disease treatment options &mdash; medications (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?13/14/13538?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16194 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-213.134.24.46-FA3CAE7412-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_14_13538=[""].join("\n");
var outline_f13_14_13538=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32695766\">",
"      What is tremor?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32695773\">",
"      What are the most common causes of resting tremor?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32695780\">",
"      What are most common causes of postural and action tremors?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32695787\">",
"      What is essential tremor?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32695794\">",
"      Is there a test to find out the cause of tremor?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32695801\">",
"      How is tremor treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32695898\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/40/13954?source=related_link\">",
"      Patient information: Parkinson disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?5/4/5188?source=related_link\">",
"      Patient information: Parkinson disease symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/50/28449?source=related_link\">",
"      Patient information: Parkinson disease treatment options &mdash; education, support, and therapy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/63/30708?source=related_link\">",
"      Patient information: Parkinson disease treatment options &mdash; medications (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/6/34913?source=related_link\">",
"      Patient information: Tremor (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_14_13539="Longitudinal ultrasound scan tibiotalar effusion";
var content_f13_14_13539=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F61432&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F61432&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 519px\">",
"   <div class=\"ttl\">",
"    Longitudinal ultrasound scan showing needle puncturing tibiotalar effusion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 499px; height: 362px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Longitudinal ultrasound scan showing needle (arrowheads) puncturing tibiotalar effusion (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Introductory Guide to Musculoskeletal Ultrasound for the Rheumatologist, Second Edition. ISBN 978-90-313-9206-3; Bohn Stafleu van Loghum, Houten 2012. Copyright &copy; 2012.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_14_13539=[""].join("\n");
var outline_f13_14_13539=null;
var title_f13_14_13540="Erythema multiforme acral";
var content_f13_14_13540=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F62370&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F62370&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema multiforme",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple acrally distributed target lesions and mucosal erosions are present in this patient with erythema multiforme majus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_14_13540=[""].join("\n");
var outline_f13_14_13540=null;
var title_f13_14_13541="Oxymetazoline (nasal): Drug information";
var content_f13_14_13541=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Oxymetazoline (nasal): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?23/25/23956?source=see_link\">",
"    see \"Oxymetazoline (nasal): Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/52/22340?source=see_link\">",
"    see \"Oxymetazoline (nasal): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block spa drugH1Div\" id=\"F15512120\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Special Alerts",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      FDA Issues Warning on Accidental Ingestion of Imidazoline Derivative Eye Drops and Nasal Sprays",
"     </span>",
"     <span class=\"collapsible-date\">",
"      October 2012",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       The U.S. Food and Drug Administration (FDA) has issued a warning that accidental ingestion by children of over-the-counter (OTC) imidazoline derivative eye drops and nasal sprays may result in serious harm. The eye drops and nasal sprays involved in cases of accidental ingestion contain the imidazoline derivatives tetrahydrozoline, oxymetazoline, or naphazoline. Serious adverse reactions (eg, coma, bradycardia, respiratory depression, sedation) requiring hospitalization were reported in children &le;5 years who had ingested even small amounts (eg, 1-2 mL). These products should be stored out of reach of children at all times; parents and caregivers should note that not all products are packaged in child-resistant packaging. If a child accidentally ingests these products, parents and caregivers should contact a poison control center at 1-800-222-1222 and seek emergency medical care immediately.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       For more information, please refer to:",
"       <a href=\"file://www.fda.gov/Drugs/DrugSafety/ucm325257.htm\" target=\"_blank\">",
"        file://www.fda.gov/Drugs/DrugSafety/ucm325257.htm",
"       </a>",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9504215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      12 Hour Nasal Relief [OTC];",
"     </li>",
"     <li>",
"      4-Way&reg; 12 Hour [OTC];",
"     </li>",
"     <li>",
"      Afrin&reg; Extra Moisturizing [OTC];",
"     </li>",
"     <li>",
"      Afrin&reg; Original [OTC];",
"     </li>",
"     <li>",
"      Afrin&reg; Severe Congestion [OTC];",
"     </li>",
"     <li>",
"      Afrin&reg; Sinus [OTC];",
"     </li>",
"     <li>",
"      Dristan&reg; [OTC];",
"     </li>",
"     <li>",
"      Duramist Plus [OTC];",
"     </li>",
"     <li>",
"      Neo-Synephrine&reg; Nighttime12-Hour [OTC];",
"     </li>",
"     <li>",
"      Nostrilla&reg; [OTC];",
"     </li>",
"     <li>",
"      NRS&reg; [OTC];",
"     </li>",
"     <li>",
"      Vicks&reg; Sinex&reg; VapoSpray 12-Hour;",
"     </li>",
"     <li>",
"      Vicks&reg; Sinex&reg; VapoSpray 12-Hour UltraFine Mist [OTC];",
"     </li>",
"     <li>",
"      Vicks&reg; Sinex&reg; VapoSpray Moisturizing 12-Hour UltraFine Mist [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9504216\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Claritin&reg; Allergic Decongestant;",
"     </li>",
"     <li>",
"      Dristan&reg; Long Lasting Nasal;",
"     </li>",
"     <li>",
"      Drixoral&reg; Nasal",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F9507255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Adrenergic Agonist Agent;",
"     </li>",
"     <li>",
"      Decongestant;",
"     </li>",
"     <li>",
"      Imidazoline Derivative",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F9504424\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     <b>",
"      Nasal congestion:",
"     </b>",
"     Intranasal:  Instill 2-3 sprays into each nostril twice daily for &le;3 days",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F9504423\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/52/22340?source=see_link\">",
"      see \"Oxymetazoline (nasal): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     <b>",
"      Nasal congestion:",
"     </b>",
"     Intranasal: Children &ge;6 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F9504425\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F9504460\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, intranasal, as hydrochloride [mist]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Original: 0.05% (15 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Vicks&reg; Sinex&reg; VapoSpray 12-Hour UltraFine Mist: 0.05% (15 mL) [contains benzalkonium chloride, menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Vicks&reg; Sinex&reg; VapoSpray Moisturizing 12-Hour UltraFine Mist: 0.05% (15 mL) [contains aloe, benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, intranasal, as hydrochloride [mist/no drip formula]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Extra Moisturizing: 0.05% (15 mL) [contains benzyl alcohol, glycerin]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Original: 0.05% (15 mL) [contains benzalkonium chloride, benzyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Severe Congestion: 0.05% (15 mL) [contains benzalkonium chloride, benzyl alcohol, camphor, menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Sinus: 0.05% (15 mL) [contains benzalkonium chloride, benzyl alcohol, camphor, menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, intranasal, as hydrochloride [spray]: 0.05% (15 mL, 30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     12 Hour Nasal Relief: 0.05% (15 mL, 30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4-Way&reg; 12 Hour: 0.05% (15 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Extra Moisturizing: 0.05% (15 mL) [contains benzalkonium chloride, glycerin]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Original: 0.05% (15 mL, 30 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Severe Congestion: 0.05% (15 mL) [contains benzalkonium chloride, benzyl alcohol, camphor, menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Sinus: 0.05% (15 mL) [contains benzalkonium chloride, benzyl alcohol, camphor, menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dristan&reg;: 0.05% (15 mL) [contains benzalkonium chloride, benzyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Duramist Plus: 0.05% (15 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neo-Synephrine&reg; Nighttime12-Hour: 0.05% (15 mL) [contains benzalkonium chloride, glycerin]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Nostrilla&reg;: 0.05% (15 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     NRS&reg;: 0.05% (15 mL, 30 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Vicks&reg; Sinex&reg; VapoSpray 12-Hour: 0.05% (15 mL) [contains benzalkonium chloride]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F9504218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Intranasal solution (spray)",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F9504219\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunctive therapy for nasal congestion, associated with acute or chronic rhinitis, the common cold, sinusitis, hay fever, or other allergies",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9504320\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Oxymetazoline may be confused with oxymetholone",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Afrin&reg; may be confused with aspirin",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Afrin&reg; (oxymetazoline) may be confused with Afrin&reg; (saline)",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Neo-Synephrine&reg; (oxymetazoline) may be confused with Neo-Synephrine&reg; (phenylephrine, nasal)",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Accidental ingestion: Serious adverse reactions (eg, coma, bradycardia, respiratory depression, sedation) requiring hospitalization have been reported in children &le;5 years of age who have accidentally ingested even small amounts (eg, 1-2 mL) of imidazoline-derivative (ie, tetrahydrozoline, oxymetazoline, or naphazoline) eye drops or nasal sprays. Store these products out of reach of children at all times. Contact poison control or seek medical attention if accidental ingestion occurs.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F9504407\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Respiratory: Dryness of the nasal mucosa, nasal irritation (temporary), rebound congestion (chronic use), sneezing",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F9504221\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to oxymetazoline or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F9504222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Rebound nasal congestion: May occur with extended use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with hypertension, heart failure, or  coronary artery disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use with caution in patients with diabetes mellitus.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperthyroidism: Use with caution in patients with hyperthyroidism.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia: Use with caution in patients with benign prostatic hyperplasia.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F9504410\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Blockers: May diminish the hypertensive effect of Alpha1-Agonists. Similarly, Alpha1-Agonists may antagonize hypotensive effects of Alpha1-Blockers. Alpha1-Blockers may diminish the vasoconstricting effect of Alpha1-Agonists. Similarly, Alpha1-Agonists may antagonize Alpha1-Blocker vasodilation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: May enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ergot Derivatives: May enhance the hypertensive effect of Alpha1-Agonists. Ergot Derivatives may enhance the vasoconstricting effect of Alpha1-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ergoloid Mesylates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FentaNYL: Alpha1-Agonists may decrease the serum concentration of FentaNYL. Specifically, fentanyl nasal spray serum concentrations may decrease and onset of effect may be delayed.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Sympathomimetics may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the hypertensive effect of Alpha1-Agonists.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: May enhance the vasopressor effect of Alpha1-Agonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F12711040\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse fetal or neonatal effects have not been observed following normal maternal doses of oxymetazoline during the third trimester of pregnancy. Adverse events have been noted in case reports following large doses or extended use. Decongestants are not the preferred agents for the treatment of rhinitis during pregnancy. Short-term (&lt;3 days) use of intranasal oxymetazoline may be beneficial to some patients although its safety during pregnancy has not been studied.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322391\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Afrin 12 Hour Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05% (30 mL): $4.80",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Afrin All Night NoDrip Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05% (15 mL): $5.76",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Afrin Extra Moisturizing Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05% (30 mL): $7.24",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Afrin Menthol Spray Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05% (15 mL): $5.27",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Afrin Nasal Spray Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05% (15 mL): $5.02",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Afrin Saline Nasal Mist Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.65% (30 mL): $2.66",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Afrin Sinus Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05% (15 mL): $5.27",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Dristan Spray Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05% (15 mL): $4.79",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Duration Spray Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05% (15 mL): $3.59",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Mucinex Nasal Spray Full Force Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05% (22 mL): $8.66",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Mucinex Nasal Spray Moisture Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05% (22 mL): $8.66",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Neo-Synephrine 12 Hour Spray Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05% (15 mL): $4.27",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Vicks Sinex 12 Hour Decongest Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05% (15 mL): $6.68",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F11390235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Afrin (BG, CO, HK, ID, PE, SG, VE);",
"     </li>",
"     <li>",
"      Alrin (IL);",
"     </li>",
"     <li>",
"      Aturgyl (FR);",
"     </li>",
"     <li>",
"      Dan Zhong Di Be Ye (CL);",
"     </li>",
"     <li>",
"      Dimetapp 12 Hour Decongestant Spray (AU, NZ);",
"     </li>",
"     <li>",
"      Drixine (AU, NZ, PH);",
"     </li>",
"     <li>",
"      Iliadin (CN, DK, HK, ID, NO, PE, SE, TH, TR, ZA);",
"     </li>",
"     <li>",
"      Lidil (UY);",
"     </li>",
"     <li>",
"      Metzodin (TH);",
"     </li>",
"     <li>",
"      Nafazol (CO);",
"     </li>",
"     <li>",
"      Nasal Spray (PY);",
"     </li>",
"     <li>",
"      Nasavin (PK);",
"     </li>",
"     <li>",
"      Nasex (PT);",
"     </li>",
"     <li>",
"      Nasin (VE);",
"     </li>",
"     <li>",
"      Nasivin (AT, BR, CH, CZ, DE, HN, NL, PL, RU);",
"     </li>",
"     <li>",
"      Nasivion (IN);",
"     </li>",
"     <li>",
"      Nesivine (BE);",
"     </li>",
"     <li>",
"      Nezeril (SE);",
"     </li>",
"     <li>",
"      Oxamet (CZ);",
"     </li>",
"     <li>",
"      Oxymet (TH);",
"     </li>",
"     <li>",
"      Respibien (PE);",
"     </li>",
"     <li>",
"      Rhinex (NO);",
"     </li>",
"     <li>",
"      Rhinoclir (IL);",
"     </li>",
"     <li>",
"      Rinerge (PK);",
"     </li>",
"     <li>",
"      Sindecon (TW);",
"     </li>",
"     <li>",
"      Vicks Sinex (AU, BE, CH, FI, IE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F9504416\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stimulates alpha-adrenergic receptors in the arterioles of the nasal mucosa to produce vasoconstriction",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F9504418\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Within seconds",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Up to 12 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9896 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-B3AA2FA6DE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_14_13541=[""].join("\n");
var outline_f13_14_13541=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15512120\">",
"      Special Alerts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504215\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504216\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9507255\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504424\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504423\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504425\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504460\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504218\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504219\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504320\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504407\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504221\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504222\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299804\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504410\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12711040\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322391\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11390235\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504416\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504418\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9896\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9896|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?23/25/23956?source=related_link\">",
"      Oxymetazoline (nasal): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/52/22340?source=related_link\">",
"      Oxymetazoline (nasal): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?9/46/9955?source=related_link\">",
"      Oxymetazoline (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?2/0/2052?source=related_link\">",
"      Oxymetazoline (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/40/32386?source=related_link\">",
"      Oxymetazoline (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_14_13542="Arterial supply of the femoral head and neck";
var content_f13_14_13542=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F74955&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F74955&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 599px\">",
"   <div class=\"ttl\">",
"    Arterial supply of the femoral head and neck",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 579px; height: 312px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The lateral ascending cervical arteries provide the blood supply to the majority of the femoral head. Foveal vessels may supply a varying area directly adjacent to the insertion of the ligamentum. There is little to no direct contribution to the head from the anterior vessels.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Baumgaertner MR, Higgins TF. Femoral neck fractures. In: Rockwood and Green's Fractures in Adults, 5th ed,&nbsp;Bucholz RW, Heckman JD (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2002. Copyright &copy; 2002 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_14_13542=[""].join("\n");
var outline_f13_14_13542=null;
var title_f13_14_13543="ECG AV canal defect";
var content_f13_14_13543=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F86336&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F86336&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 610px\">",
"   <div class=\"ttl\">",
"    Electrocardiogram in a patient with atrioventricular (AV) canal defect",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 590px; height: 296px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram in a patient with atrioventricular (AV) canal defect with a characteristic leftward and superior QRS axis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_14_13543=[""].join("\n");
var outline_f13_14_13543=null;
var title_f13_14_13544="Noncardiac surgery in patients with aortic stenosis";
var content_f13_14_13544=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Noncardiac surgery in patients with aortic stenosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/14/13544/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/14/13544/contributors\">",
"     Anna M Booher, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/14/13544/contributors\">",
"     Kim A Eagle, MD, MACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/14/13544/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/14/13544/contributors\">",
"     Catherine M Otto, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/14/13544/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/14/13544/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/14/13544/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk models have identified severe aortic stenosis as a major clinical predictor of adverse outcomes (",
"    <a class=\"graphic graphic_table graphicRef62292 \" href=\"UTD.htm?26/56/27532\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef80422 \" href=\"UTD.htm?39/24/40332\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/1\">",
"     1",
"    </a>",
"    ]. Population studies from the USA and Finland reported aortic stenosis in approximately 1 to 2 percent of individuals 65 to 75 years old with prevalence increasing to 3 to 8 percent in individuals &ge; 75 years old [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. In the Helsinki Aging study, nearly 3 percent of the individuals between 75 and 86 years of age had critical aortic stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/3\">",
"     3",
"    </a>",
"    ]. These patients frequently have concurrent cardiovascular disease with approximately half of patients with aortic stenosis aged 50 years and older having concomitant coronary heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=see_link\">",
"     \"Estimation of cardiac risk prior to noncardiac surgery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/36/34377?source=see_link&amp;anchor=H17#H17\">",
"     \"Valvular heart disease in elderly adults\", section on 'Underlying atherosclerosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to the increase in perioperative risk, the presence of valvular disease has potentially important implications for the perioperative management and prognosis of the patient undergoing noncardiac surgery.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A cardiac murmur may be auscultated during the initial preoperative examination. A functional murmur should be distinguished from a pathologic murmur with a careful history and physical examination that includes cardiac maneuvers. The findings should be correlated clinically with symptoms. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=see_link\">",
"       \"Auscultation of cardiac murmurs\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41876?source=see_link\">",
"       \"Physiologic and pharmacologic maneuvers in the differential diagnosis of heart murmurs and sounds\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The presence of a prosthetic heart valve (mechanical, bioprosthetic, or homograft) is an indication for antimicrobial prophylaxis for bacterial endocarditis for certain procedures. Antimicrobial prophylaxis is no longer generally recommended in patients with native valvular disease (eg, bicuspid or calcific aortic stenosis) without prior history of endocarditis [",
"      <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/8\">",
"       8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link\">",
"       \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Interruption of chronic anticoagulation, particularly in the case of mechanical valve prostheses, prior to noncardiac surgery may be required. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/50/35626?source=see_link\">",
"       \"Management of anticoagulation before and after elective surgery\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The perioperative considerations in patients with native aortic valve stenosis who are undergoing noncardiac surgery will be reviewed here. The perioperative management of patients with aortic regurgitation, mitral valve disease, and prosthetic heart valves is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/11/13495?source=see_link\">",
"     \"Noncardiac surgery in patients with mitral or aortic regurgitation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=see_link\">",
"     \"Medical management and indications for intervention in mitral stenosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/56/15238?source=see_link\">",
"     \"Management of patients with prosthetic heart valves\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/11/18618?source=see_link\">",
"     \"Antithrombotic therapy in patients with prosthetic heart valves\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aortic stenosis results in fixed obstruction to left ventricular emptying. The stenotic process is usually gradual in onset and progression, giving the heart ample opportunity to adapt. The left ventricular (LV) myocardium hypertrophies over time, resulting in the generation of greater pressure during systole, which forces blood past the fixed mechanical obstruction. As a result, the cardiac output and left ventricular end-diastolic volume are maintained and patients can remain asymptomatic for a prolonged period of time, even with severe aortic stenosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21706?source=see_link\">",
"     \"Clinical features and evaluation of aortic stenosis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30551?source=see_link\">",
"     \"Natural history of aortic stenosis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, this chronic pressure overload state that results in the compensatory concentric LV hypertrophy also reduces the compliance of the left ventricle. As a result, diastolic dysfunction develops over time, the end diastolic pressure of the LV increases, and patients eventually develop symptoms of chest pain or dyspnea. The concentric hypertrophy also reduces coronary flow reserve, rendering the patient more susceptible to ischemia in situations of increased myocardial oxygen demand, even in the absence of obstructive coronary artery disease (CAD) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/9\">",
"     9",
"    </a>",
"    ]. In addition, due to fixed obstruction of the left ventricular outflow tract, decreases in systemic vascular resistance can result in relative systemic hypotension and subsequent ischemia from reduced coronary perfusion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21706?source=see_link\">",
"     \"Clinical features and evaluation of aortic stenosis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Therefore, clinical deterioration can occur in patients with asymptomatic AS during the hemodynamic stress associated with noncardiac surgery (as well as other states that require augmentation of cardiac output such as infection, anemia, or pregnancy). Many adverse events occur because the diagnosis of AS was not known to the surgical team. Preoperative echocardiographic should be performed for evaluation of any murmur that is not clearly benign based on physical exam.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PREOPERATIVE ASSESSMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9305917\">",
"    <span class=\"h2\">",
"     Key steps",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following are key steps in the management of patients with suspected AS who need noncardiac surgery:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Evaluation of symptoms and signs of cardiac disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Preoperative echocardiographic assessment of aortic stenosis severity and ventricular function",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Careful evaluation for coexisting coronary artery disease and other cardiac risk factors (",
"      <a class=\"graphic graphic_table graphicRef57075 \" href=\"UTD.htm?42/4/43083\">",
"       table 3",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The above evaluation will enable recognition of AS, determination of its severity, and identification of any concomitant cardiac disease. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9306402\">",
"    <span class=\"h2\">",
"     Recognition of AS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aortic stenosis may be initially recognized on physical examination by the presence of a systolic \"ejection\" murmur (",
"    <a class=\"graphic graphic_movie graphicRef67896 \" href=\"UTD.htm?13/13/13521\">",
"     movie 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef77091 \" href=\"UTD.htm?39/8/40065\">",
"     movie 2",
"    </a>",
"    ). The physical examination may also reveal one or more associated findings. These findings are briefly summarized here and are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21706?source=see_link&amp;anchor=H17#H17\">",
"     \"Clinical features and evaluation of aortic stenosis in adults\", section on 'Physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Studies evaluating the precision and accuracy of the clinical examination found that four findings were useful for diagnosis of AS [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A slow rate of rise in the carotid pulse",
"     </li>",
"     <li>",
"      Mid to late peak intensity of the murmur",
"     </li>",
"     <li>",
"      Maximal murmur intensity at the second right intercostal space",
"     </li>",
"     <li>",
"      Reduced intensity of the second heart sound",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although classic findings are helpful in identifying patients with significant AS, the physical examination is less useful for excluding the presence of severe AS in patients with a systolic murmur. Echocardiography is necessary, since none of the physical findings has both a high sensitivity and high specificity for severe valvular obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The murmur of aortic sclerosis, a common and more benign valvular abnormality seen in older individuals, is also a midsystolic murmur. In general, the murmur is brief and not very loud. A normal carotid pulse and normal S2 usually confirm the absence of AS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38279?source=see_link\">",
"     \"Aortic valve sclerosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9306332\">",
"    <span class=\"h2\">",
"     Evaluation of AS severity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of the AS includes history, physical examination, and echocardiographic assessment of AS and any concomitant cardiovascular disease as discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21706?source=see_link\">",
"     \"Clinical features and evaluation of aortic stenosis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/3/1082?source=see_link\">",
"     \"Echocardiographic evaluation of the aortic valve\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/11/1208?source=see_link\">",
"     \"Aortic valve area in aortic stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25097190\">",
"    <span class=\"h2\">",
"     Evaluation of CAD",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients without valvular heart disease, the pre-operative assessment for coronary artery disease (CAD) is made on the basis of symptoms and functional capacity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=see_link\">",
"     \"Estimation of cardiac risk prior to noncardiac surgery\"",
"    </a>",
"    .) Given the physiologic changes that occur in patients with aortic stenosis (LV hypertrophy, diastolic dysfunction, alterations in coronary flow reserve), the cause of cardiac symptoms (ie, obstructive CAD versus valvular disease) can be difficult to differentiate.",
"   </p>",
"   <p>",
"    Further complicating this issue is the frequency of concomitant aortic stenosis and CAD with the prevalence of both increasing with age. Among older patients with symptomatic AS, the prevalence of CAD is 40 to 50 percent in those with typical angina and 20 percent in those without chest pain. Even in patients with AS who are less than 40 and have no chest pain and no coronary risk factors, the prevalence of CAD may be as high as 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21706?source=see_link\">",
"     \"Clinical features and evaluation of aortic stenosis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We recommend assessment of the presence of CAD in patients with AS prior to elective noncardiac surgery when the patient is symptomatic with chest pain or angina equivalent, has evidence of heart failure that has not been previously assessed, or a recent acute coronary syndrome. In addition, we suggest CAD assessment in asymptomatic patients with &gt;2 risk factors for CAD who require intermediate or high risk surgery, given the high prevalence of concomitant disease in patients with AS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=see_link\">",
"     \"Estimation of cardiac risk prior to noncardiac surgery\"",
"    </a>",
"    .) In patients requiring urgent or emergent surgery, the evaluation for obstructive CAD should not delay a necessary noncardiac operation.",
"   </p>",
"   <p>",
"    The following considerations guide the choice of test in patients with AS undergoing evaluation for CAD [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      ECG stress testing alone is generally not sufficient for evaluation of CAD in patients with AS. The resting and exercise ECG in patients with valvular heart disease frequently shows ST-segment changes due to left ventricular hypertrophy, left ventricular chamber dilatation, or bundle-branch block, which reduces the accuracy of the ECG at rest and during exercise for the diagnosis of concomitant CAD.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Noninvasive imaging (eg, radionuclide or echocardiographic) stress testing can be useful in patients with mild or moderate AS without baseline wall motion abnormalities.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Given the importance of determining the presence of CAD, coronary angiography remains the most appropriate method for the definitive diagnosis of CAD in patients with severe AS [",
"      <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/15\">",
"       15",
"      </a>",
"      ]. Noninvasive imaging may not be helpful in patients with severe AS with left ventricular hypertrophy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      chamber dilatation since resting or stress-induced regional wall motion abnormalities or myocardial perfusion abnormalities are nonspecific markers for CAD in such patients [",
"      <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/16,17\">",
"       16,17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9307098\">",
"    <span class=\"h2\">",
"     Estimation of risk of noncardiac surgery",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9306874\">",
"    <span class=\"h3\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of perioperative cardiac complications from noncardiac surgery in patients with AS varies with the severity of AS and the presence of other cardiac risk factors, including ischemic heart disease (see",
"    <a class=\"local\" href=\"#H25097190\">",
"     'Evaluation of CAD'",
"    </a>",
"    above) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/18\">",
"     18",
"    </a>",
"    ]. Perioperative complications include myocardial infarction, hypotension, heart failure, arrhythmias, and death. The risk of noncardiac surgery is also dependent upon the risk category of the surgical procedure; minor procedures with local anesthesia entail less risk.",
"   </p>",
"   <p>",
"    General issues related to the estimation and management of cardiac risk prior to noncardiac surgery, including initial risk assessment, the role of noninvasive testing and possible cardiac catheterization, and the indications for beta blocker and statin therapy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=see_link\">",
"     \"Estimation of cardiac risk prior to noncardiac surgery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/45/29402?source=see_link\">",
"     \"Management of cardiac risk for noncardiac surgery\"",
"    </a>",
"    .) However, most preoperative risk models do not include aortic stenosis as a risk factor because this condition was not adequately represented in the populations from which these risk assessment tools were generated. The following discussion will review issues specific to the perioperative risk associated with known aortic stenosis.",
"   </p>",
"   <p>",
"    The presence of AS, even if less than severe or asymptomatic, is associated with increased risk of postoperative adverse cardiac events after noncardiac surgery as identified in the 1977 study that led to the initial Goldman cardiac risk index for noncardiac surgical procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of cardiac complications in patients with AS undergoing noncardiac surgery is approximately 10 to 30 percent, with higher risk in those with severe AS as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Perioperative risk of noncardiac surgery was compared in 5149 patients diagnosed with AS (severity not specified) and 10,284 controls from the National Hospital Discharge Survey database [",
"      <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/21\">",
"       21",
"      </a>",
"      ]. The risk of myocardial infarction or death was significantly higher in patients with AS compared to controls (8.3 versus 7.2 percent) due to a higher risk of myocardial infarction (3.9 versus 2.0 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A study from the Netherlands of 108 patients with moderate or severe AS and 216 controls found that those with AS had significantly more frequent perioperative events (mortality and nonfatal myocardial infarction) compared with those without AS (14 versus 2 percent; adjusted odds ratio of 5.2) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/18\">",
"       18",
"      </a>",
"      ]. The risk of complications was greater in those with severe AS compared to those with moderate AS (31 versus 11 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The risk of mortality in patients with severe AS undergoing intermediate or higher risk surgery has been estimated to be approximately 10 percent but data on perioperative outcomes are scant, as illustrated by the following studies:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A Mayo Clinic study included 19 patients with severe AS (aortic valve area &lt;0.5",
"      <span class=\"nowrap\">",
"       cm",
"       <sup>",
"        2",
"       </sup>",
"       /m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      or mean aortic valve gradient of &gt;50 mm Hg) who underwent 28 noncardiac surgical procedures at a tertiary care center [",
"      <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/22\">",
"       22",
"      </a>",
"      ]. Most of the patients (84 percent) had symptomatic AS. All intraoperative hypotension was promptly treated. Two patients (10.5 percent) had complicated postoperative courses and in-hospital death.",
"     </li>",
"     <li>",
"      A later Mayo Clinic Scottsdale study compared perioperative outcomes of noncardiac surgery for 30 patients with asymptomatic severe AS (aortic valve area &lt;1.0 cm",
"      <sup>",
"       2",
"      </sup>",
"      or mean gradient &gt;40 mm Hg) to those for 60 controls with mild to moderate AS [",
"      <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/23\">",
"       23",
"      </a>",
"      ]. Postoperative events were nearly significantly more frequent in those with severe AS compared to those with mild to moderate AS (33 versus 23 percent; p = 0.06). No deaths occurred among those with severe AS and one death occurred among those with mild to moderate AS.",
"     </li>",
"     <li>",
"      A study from Jerusalem compared outcomes following repair of hip fracture in 32 patients over 70 years old with severe AS (aortic valve area &le;1.0 cm",
"      <sup>",
"       2",
"      </sup>",
"      ) with 88 age-matched controls [",
"      <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The risk of perioperative cardiac complications in patients with AS is also dependent upon presence of concurrent risk factors. In the retrospective study from the Netherlands discussed above [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/18\">",
"     18",
"    </a>",
"    ], 18 of 108 patients with moderate to severe AS with a Revised Goldman Cardiac Risk Index (RCRI) of 0 (",
"    <a class=\"graphic graphic_table graphicRef57075 \" href=\"UTD.htm?42/4/43083\">",
"     table 3",
"    </a>",
"    ) had no adverse perioperative events [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/18\">",
"     18",
"    </a>",
"    ]. In contrast, patients with AS with RCRIs of 1 to &gt;3 had perioperative event rates ranging from 10 to 29 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=see_link&amp;anchor=H21#H21\">",
"     \"Estimation of cardiac risk prior to noncardiac surgery\", section on 'Revised cardiac risk index'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9306881\">",
"    <span class=\"h3\">",
"     Increased risk of bleeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with moderate to severe aortic stenosis have a bleeding tendency due to an acquired von Willebrand syndrome, which may increase the risk associated with noncardiac surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21706?source=see_link&amp;anchor=H27#H27\">",
"     \"Clinical features and evaluation of aortic stenosis in adults\", section on 'Bleeding tendency'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9306534\">",
"    <span class=\"h1\">",
"     PREOPERATIVE MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9306542\">",
"    <span class=\"h2\">",
"     Decisions before noncardiac surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The above preoperative assessment will enable estimation of the risk of noncardiac surgery and determination of whether preoperative valve replacement is indicated. The necessity of the proposed noncardiac surgery should be carefully evaluated.",
"   </p>",
"   <p>",
"    As discussed above, observational data suggest that careful management, selected patients with AS, particularly those with asymptomatic disease and without significant coronary artery disease, can undergo noncardiac procedures with an acceptable risk [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/18,21,22,26\">",
"     18,21,22,26",
"    </a>",
"    ]. The anesthesia team should be aware of the presence and severity of AS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Patients with indications for AVR",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9307934\">",
"    <span class=\"h3\">",
"     Surgical AVR",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with AS who have indications for aortic valve replacement (such as symptomatic severe AS), we recommend postponing elective noncardiac surgery since severe AS is a risk factor for perioperative morbidity and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/8,27\">",
"     8,27",
"    </a>",
"    ]. The indications for aortic valve replacement are the same as in the absence of planned noncardiac surgery (",
"    <a class=\"graphic graphic_table graphicRef68344 \" href=\"UTD.htm?29/2/29740\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/1,8\">",
"     1,8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/8/31881?source=see_link\">",
"     \"Indications for valve replacement in aortic stenosis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6572654\">",
"    <span class=\"h3\">",
"     Alternatives to surgical AVR",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aortic valve replacement prior to noncardiac surgery is not always feasible, as some patients require an urgent noncardiac procedure, some may be at high risk for adverse outcomes from valvular surgery, and some may decline aortic valve surgery. Options for these patients include proceeding directly with the noncardiac surgery with careful perioperative management or first performing transcatheter aortic valve replacement (TAVR). The role of balloon aortic valvuloplasty (BAV) in these patients is uncertain.",
"   </p>",
"   <p>",
"    Limited observational data suggest that with careful hemodynamic monitoring, selected patients with severe AS who are not candidates for or decline aortic valve replacement can undergo noncardiac procedures at an acceptable risk, particularly in the absence of significant coronary artery disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/18,21,22,26\">",
"     18,21,22,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h4\">",
"     Role of TAVR or BAV",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transcatheter aortic valve replacement (TAVR) is a potential alternative to surgical aortic valve replacement for selected patients with AS with indications for aortic valve replacement for whom the risk of surgical valve replacement is prohibitive. Although data are lacking, TAVR may be helpful in selected high risk AS patients prior to required noncardiac surgery.",
"   </p>",
"   <p>",
"    The role of percutaneous balloon aortic valvotomy (BAV) in patients with severe AS requiring noncardiac surgery is uncertain. The use of BAV is limited in older adults with AS because complications (eg, stroke, acute aortic regurgitation, and myocardial infarction) occur in approximately 10 to 20 percent of patients. Restenosis and clinical deterioration occur in most cases within 6 to 12 months. Data are limited on the efficacy of this approach in general and as applied to preparation for noncardiac surgery (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/31/39411?source=see_link\">",
"     \"Percutaneous aortic valvotomy\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two small studies, each with only seven patients who had symptomatic AS, evaluated the outcomes in patients who underwent BAV prior to noncardiac surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/28,29\">",
"       28,29",
"      </a>",
"      ]. There were no deaths, strokes, or conduction abnormalities in either series. One patient developed a pseudoaneurysm of the femoral artery.",
"     </li>",
"     <li>",
"      The outcomes were not as good in a report of 15 patients with symptomatic severe AS who underwent either noncardiac surgery or an invasive diagnostic procedure following BAV [",
"      <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/30\">",
"       30",
"      </a>",
"      ]. There were adverse outcomes in five patients, including one fatality. Among the 14 patients who survived BAV, there were no adverse surgical outcomes associated with either the noncardiac surgery or subsequent invasive diagnostic procedure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    valvular guidelines did not recommend routine balloon valvotomy in the preoperative setting, with the possible exception of certain younger adults without valve calcification [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/8\">",
"     8",
"    </a>",
"    ]. The 2012 ESC guidelines note that balloon valvuloplasty or transcatheter aortic valve replacement (TAVR) may be considered in selected patients with symptomatic AS at high risk for adverse outcomes with valve surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9306142\">",
"    <span class=\"h1\">",
"     PERIOPERATIVE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anesthesia team should be aware of the presence and severity of AS and other cardiac risk factors.",
"   </p>",
"   <p>",
"    For patients with severe AS undergoing major surgical procedures, we suggest invasive hemodynamic monitoring to ensure that left ventricular preload is maintained in an optimal range. Hemodynamic monitoring should begin 12 to 24 hours preoperatively and continue for 24 to 48 hours postoperatively to cover the time period when major shifts in intravascular volume are likely to occur. In contrast, among patients with mild to moderate AS or patients with AS undergoing minor surgical procedures, noninvasive monitoring of the electrocardiogram, blood pressure, and oxygen saturation by an experienced anesthesiologist is usually adequate.",
"   </p>",
"   <p>",
"    Management recommendations are based in part upon observation of the following pathophysiologic changes with AS:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The chronic pressure overload state results in concentric hypertrophy, thereby reducing the compliance of the left ventricle.",
"     </li>",
"     <li>",
"      The concentric hypertrophy also reduces coronary reserve as discussed above, rendering the patient more susceptible to ischemia in situations of increased myocardial oxygen demand with and without the presence of concomitant CAD. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21706?source=see_link\">",
"       \"Clinical features and evaluation of aortic stenosis in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These observations support the following treatment principles [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Maintenance of normal sinus rhythm with a moderate heart rate is important. Because the atrial \"kick\" may provide up to 40 percent of ventricular filling in patients with diastolic dysfunction or reduced LV compliance, rhythms other than sinus rhythm can have deleterious hemodynamic effects. In particular, atrial fibrillation with rapid ventricular response may be poorly tolerated. Since stroke volume across the stenotic valve is relatively fixed, bradycardia (HR &lt;40) should also be avoided.",
"     </li>",
"     <li>",
"      Both vascular volume and preload must be maintained. Marked reductions in preload, as may be induced by anesthetics or other drugs, may be poorly tolerated because of impaired left ventricular compliance. It is probably better to err on the side of minimal volume overload than hypovolemia.",
"     </li>",
"     <li>",
"      Sudden reductions in systemic vascular resistance, as may be induced by epidural or spinal anesthesia, may result in a substantial decrease in coronary perfusion. Thus, anesthesia techniques should be tailored to maintain an adequate systemic vascular resistance.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hypotension after induction of anesthesia should be treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/36/39488?source=see_link\">",
"     phenylephrine",
"    </a>",
"    , an alpha agonist that has no chronotropic properties. Small studies have demonstrated efficacy of an intravenous phenylephrine bolus during episodes of hypotension [",
"    <a class=\"abstract\" href=\"UTD.htm?13/14/13544/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. However, the patients in these reports had mainly isolated AS, no significant coronary artery disease, and normal left ventricular function.",
"   </p>",
"   <p>",
"    These principles apply before and during the surgical procedure and in the 48 to 72 hour postoperative period when major shifts in intravascular volume may occur, depending upon the type of surgical procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with significant AS are at increased risk for cardiac complications, including intraoperative hypotension, myocardial infarction, ischemia, heart failure, arrhythmias, and death. (See",
"      <a class=\"local\" href=\"#H9307098\">",
"       'Estimation of risk of noncardiac surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Perioperative risk increases with AS severity and presence of concomitant cardiac risk factors, including ischemic heart disease which is prevalent in patients with aortic stenosis. As a result, assessment of an individual patient&rsquo;s risk is best thought of as a global cardiac risk assessment. (See",
"      <a class=\"local\" href=\"#H9306874\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with symptomatic severe aortic stenosis should have elective noncardiac surgery delayed when possible. Patients with indications for corrective aortic valve surgery should undergo valve replacement prior to elective noncardiac surgery (",
"      <a class=\"graphic graphic_table graphicRef68344 \" href=\"UTD.htm?29/2/29740\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Patients with indications for AVR'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Valve replacement is not feasible in some patients with indications for aortic valve surgery (eg, urgent or emergent life-saving surgery, multiple medical comorbidities, or patient refusal). Limited observational data suggest that perioperative risk can be managed with careful intraoperative monitoring in selected patients with severe, asymptomatic, or even symptomatic aortic stenosis, particularly those with no significant coronary artery disease. (See",
"      <a class=\"local\" href=\"#H9306534\">",
"       'Preoperative management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Preoperative recognition of the severity of AS and any concomitant cardiac disease and communication with the anesthesiologist is essential. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Preoperative assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Perioperative management should include preventing prolonged tachycardia due to atrial arrhythmia and avoiding sudden reductions in preload and systemic vascular resistance are important perioperative hemodynamic goals. We suggest invasive monitoring in patients with severe AS. (See",
"      <a class=\"local\" href=\"#H9306142\">",
"       'Perioperative management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H868844\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The UpToDate editorial staff would&nbsp;like to thank Drs. Michelle V. Conde and Joe M. Moody for their contributions as authors to previous versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/1\">",
"      Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2009; 120:e169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/2\">",
"      Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 29:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/3\">",
"      Lindroos M, Kupari M, Heikkil&auml; J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993; 21:1220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/4\">",
"      Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/5\">",
"      Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 2011; 8:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/6\">",
"      Mullany CJ, Elveback LR, Frye RL, et al. Coronary artery disease and its management: influence on survival in patients undergoing aortic valve replacement. J Am Coll Cardiol 1987; 10:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/7\">",
"      Levinson JR, Akins CW, Buckley MJ, et al. Octogenarians with aortic stenosis. Outcome after aortic valve replacement. Circulation 1989; 80:I49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/8\">",
"      Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/9\">",
"      Banovic MD, Vujisic-Tesic BD, Kujacic VG, et al. Coronary flow reserve in patients with aortic stenosis and nonobstructed coronary arteries. Acta Cardiol 2011; 66:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/10\">",
"      Etchells E, Bell C, Robb K. Does this patient have an abnormal systolic murmur? JAMA 1997; 277:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/11\">",
"      Etchells E, Glenns V, Shadowitz S, et al. A bedside clinical prediction rule for detecting moderate or severe aortic stenosis. J Gen Intern Med 1998; 13:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/12\">",
"      Green SJ, Pizzarello RA, Padmanabhan VT, et al. Relation of angina pectoris to coronary artery disease in aortic valve stenosis. Am J Cardiol 1985; 55:1063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/13\">",
"      Chobadi R, Wurzel M, Teplitsky I, et al. Coronary artery disease in patients 35 years of age or older with valvular aortic stenosis. Am J Cardiol 1989; 64:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/14\">",
"      Lombard JT, Selzer A. Valvular aortic stenosis. A clinical and hemodynamic profile of patients. Ann Intern Med 1987; 106:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/15\">",
"      Graboys TB, Cohn PF. The prevalence of angina pectoris and abnormal coronary arteriograms in severe aortic valvular disease. Am Heart J 1977; 93:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/16\">",
"      Osbakken M, Bove AA, Spann JF. Left ventricular function in chronic aortic regurgitation with reference to end-systolic pressure, volume and stress relations. Am J Cardiol 1981; 47:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/17\">",
"      Kupari M, Virtanen KS, Turto H, et al. Exclusion of coronary artery disease by exercise thallium-201 tomography in patients with aortic valve stenosis. Am J Cardiol 1992; 70:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/18\">",
"      Kertai MD, Bountioukos M, Boersma E, et al. Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. Am J Med 2004; 116:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/19\">",
"      Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/20\">",
"      Goldman L. Aortic stenosis in noncardiac surgery: underappreciated in more ways than one? Am J Med 2004; 116:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/21\">",
"      Zahid M, Sonel AF, Saba S, Good CB. Perioperative risk of noncardiac surgery associated with aortic stenosis. Am J Cardiol 2005; 96:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/22\">",
"      Torsher LC, Shub C, Rettke SR, Brown DL. Risk of patients with severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol 1998; 81:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/23\">",
"      Calleja AM, Dommaraju S, Gaddam R, et al. Cardiac risk in patients aged &gt;75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol 2010; 105:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/24\">",
"      Leibowitz D, Rivkin G, Schiffman J, et al. Effect of severe aortic stenosis on the outcome in elderly patients undergoing repair of hip fracture. Gerontology 2009; 55:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/25\">",
"      Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003; 349:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/26\">",
"      Raymer K, Yang H. Patients with aortic stenosis: cardiac complications in non-cardiac surgery. Can J Anaesth 1998; 45:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/27\">",
"      Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33:2451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/28\">",
"      Levine MJ, Berman AD, Safian RD, et al. Palliation of valvular aortic stenosis by balloon valvuloplasty as preoperative preparation for noncardiac surgery. Am J Cardiol 1988; 62:1309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/29\">",
"      Roth RB, Palacios IF, Block PC. Percutaneous aortic balloon valvuloplasty: its role in the management of patients with aortic stenosis requiring major noncardiac surgery. J Am Coll Cardiol 1989; 13:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/30\">",
"      Hayes SN, Holmes DR Jr, Nishimura RA, Reeder GS. Palliative percutaneous aortic balloon valvuloplasty before noncardiac operations and invasive diagnostic procedures. Mayo Clin Proc 1989; 64:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/31\">",
"      Mittnacht AJ, Fanshawe M, Konstadt S. Anesthetic considerations in the patient with valvular heart disease undergoing noncardiac surgery. Semin Cardiothorac Vasc Anesth 2008; 12:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/32\">",
"      Christ M, Sharkova Y, Geldner G, Maisch B. Preoperative and perioperative care for patients with suspected or established aortic stenosis facing noncardiac surgery. Chest 2005; 128:2944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/33\">",
"      Goertz AW, Lindner KH, Seefelder C, et al. Effect of phenylephrine bolus administration on global left ventricular function in patients with coronary artery disease and patients with valvular aortic stenosis. Anesthesiology 1993; 78:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/14/13544/abstract/34\">",
"      Goertz AW, Lindner KH, Sch&uuml;tz W, et al. Influence of phenylephrine bolus administration on left ventricular filling dynamics in patients with coronary artery disease and patients with valvular aortic stenosis. Anesthesiology 1994; 81:49.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8124 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-3918385851-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_14_13544=[""].join("\n");
var outline_f13_14_13544=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PREOPERATIVE ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9305917\">",
"      Key steps",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9306402\">",
"      Recognition of AS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9306332\">",
"      Evaluation of AS severity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25097190\">",
"      Evaluation of CAD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9307098\">",
"      Estimation of risk of noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9306874\">",
"      - Risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9306881\">",
"      - Increased risk of bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9306534\">",
"      PREOPERATIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9306542\">",
"      Decisions before noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Patients with indications for AVR",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9307934\">",
"      - Surgical AVR",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6572654\">",
"      - Alternatives to surgical AVR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Role of TAVR or BAV",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9306142\">",
"      PERIOPERATIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H868844\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/8124\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8124|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?13/13/13521\" title=\"movie 1\">",
"      Phonocardiogram calcific AS 3rd left ICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?39/8/40065\" title=\"movie 2\">",
"      Phonocardiogram bicusid AS at 2nd R ICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8124|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/56/27532\" title=\"table 1\">",
"      ACC AHA prediction periop risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/24/40332\" title=\"table 2\">",
"      Detsky cardiac risk index",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/4/43083\" title=\"table 3\">",
"      Revised cardiac risk index",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/2/29740\" title=\"table 4\">",
"      ACC AHA AVR in aortic stenosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/11/18618?source=related_link\">",
"      Antithrombotic therapy in patients with prosthetic heart valves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/11/1208?source=related_link\">",
"      Aortic valve area in aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38279?source=related_link\">",
"      Aortic valve sclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=related_link\">",
"      Auscultation of cardiac murmurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21706?source=related_link\">",
"      Clinical features and evaluation of aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/3/1082?source=related_link\">",
"      Echocardiographic evaluation of the aortic valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=related_link\">",
"      Estimation of cardiac risk prior to noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/8/31881?source=related_link\">",
"      Indications for valve replacement in aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/50/35626?source=related_link\">",
"      Management of anticoagulation before and after elective surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/45/29402?source=related_link\">",
"      Management of cardiac risk for noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/56/15238?source=related_link\">",
"      Management of patients with prosthetic heart valves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=related_link\">",
"      Medical management and indications for intervention in mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30551?source=related_link\">",
"      Natural history of aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/11/13495?source=related_link\">",
"      Noncardiac surgery in patients with mitral or aortic regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/31/39411?source=related_link\">",
"      Percutaneous aortic valvotomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41876?source=related_link\">",
"      Physiologic and pharmacologic maneuvers in the differential diagnosis of heart murmurs and sounds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/36/34377?source=related_link\">",
"      Valvular heart disease in elderly adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_14_13545="Clonidine: Pediatric drug information";
var content_f13_14_13545=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Clonidine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?18/53/19289?source=see_link\">",
"    see \"Clonidine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?20/7/20598?source=see_link\">",
"    see \"Clonidine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F153485\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Catapres-TTS&reg;-1;",
"     </li>",
"     <li>",
"      Catapres-TTS&reg;-2;",
"     </li>",
"     <li>",
"      Catapres-TTS&reg;-3;",
"     </li>",
"     <li>",
"      Catapres&reg;;",
"     </li>",
"     <li>",
"      Duraclon&reg;;",
"     </li>",
"     <li>",
"      Kapvay&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F153486\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Clonidine&reg;;",
"     </li>",
"     <li>",
"      Catapres&reg;;",
"     </li>",
"     <li>",
"      Dixarit&reg;;",
"     </li>",
"     <li>",
"      Dom-Clonidine;",
"     </li>",
"     <li>",
"      Novo-Clonidine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1051807\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Adrenergic Agonist Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Alpha-Adrenergic Agonist",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Analgesic, Non-narcotic (Epidural)",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antihypertensive Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F12669157\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Neonatal abstinence syndrome (opioid withdrawal):",
"     </b>",
"     Limited information; further studies needed. Oral: 0.5-1",
"     <b>",
"      mcg",
"     </b>",
"     /kg/dose every 3-6 hours (Hudak, 2012); for premature neonates, a dosing interval of every 6 hours was reported  (median GA: 26 weeks and 2 days)  (Leikin, 2009)",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1051799\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?18/53/19289?source=see_link\">",
"      see \"Clonidine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Formulations of clonidine (immediate release vs extended release) are not interchangeable on a mg:mg basis due to different pharmacokinetic profiles.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Children and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hypertension:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral: Immediate release:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Weight-directed dosing: Children and Adolescents 1-17 years: Initial: 5-10",
"     <b>",
"      mcg",
"     </b>",
"     /kg/day in divided doses every 8-12 hours; increase gradually as needed; usual range: 5-25",
"     <b>",
"      mcg",
"     </b>",
"     /kg/day in divided doses every 6 hours; maximum dose: 0.9 mg/day (Kavey, 2010; Rocchini, 1984)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Alternate dosing: Fixed dosing: Children and Adolescents &ge;12 years: Initial: 0.1 mg twice daily; increase gradually, if needed, by 0.1 mg/day at weekly intervals; usual maintenance dose: 0.2-0.6 mg/day in divided doses; maximum recommended dose: 2.4 mg/day (rarely required) (NHBPEP, 2004)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Transdermal: Children and Adolescents: May be switched to the transdermal delivery system after oral therapy is titrated to an optimal and stable dose; a transdermal dose approximately equivalent to the total oral daily dose may be used (Hunt, 1990).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hypertension, urgency and emergency:",
"     </b>",
"     Oral: Immediate release: Children and Adolescents 1-17 years: 0.05-0.1 mg/dose; may repeat dose(s) up to a maximum total dose of 0.8 mg (NHBPEP, 2004)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      ADHD:",
"     </b>",
"     Children &ge;6 years and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Immediate release (Pliszka, 2007):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     &le;45 kg: Initial: 0.05 mg at bedtime; sequentially increase every 3-7 days in 0.05 mg/day increments given as 0.05 mg twice daily, then 3 times daily, then 4 times daily; maximum daily dose weight-dependent: Patient weight: 27-40.5 kg: 0.2 mg/day; patient weight: 40.5-45 kg; 0.3 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     &gt;45 kg: Initial: 0.1 mg at bedtime; sequentially increase every 3-7 days in 0.1 mg/day increments given as 0.1 mg twice daily, then 3 times daily, then 4 times daily; maximum daily dose: 0.4 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Extended release (Kapvay&trade;): Initial: 0.1 mg at bedtime; increase in 0.1 mg/day increments every 7 days until desired response; doses should be administered twice daily (either split equally or with the higher split dosage given at bedtime); maximum: 0.4 mg/day.",
"     <b>",
"      Note:",
"     </b>",
"     Maintenance treatment for &gt;5 weeks has not been evaluated. When discontinuing therapy, taper daily dose by &le;0.1 mg every 3-7 days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Transdermal: Children may be switched to the transdermal delivery system after oral therapy is titrated to an optimal and stable dose; a transdermal dose approximately equivalent to the total oral daily dose may be used (Hunt, 1990).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Clonidine tolerance test (test of growth hormone release from the pituitary):",
"     </b>",
"     Oral: 0.15 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     or 5",
"     <b>",
"      <b>",
"       mcg",
"      </b>",
"     </b>",
"     /kg as a single dose; maximum dose: 0.250 mg (Lanes, 1982; Richmond, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Analgesia:",
"     </b>",
"     Epidural: Continuous infusion: Initial: 0.5",
"     <b>",
"      mcg",
"     </b>",
"     /kg/",
"     <b>",
"      hour",
"     </b>",
"     ; adjust with caution, based on clinical effect; usual range: 0.5-2",
"     <b>",
"      mcg",
"     </b>",
"     /kg/",
"     <b>",
"      hour",
"     </b>",
"     ; do not exceed adult doses. Do not discontinue clonidine abruptly; if needed, gradually reduce dose over 2-4 days to avoid withdrawal symptoms. Manufacturer suggests use reserved for cancer patients with severe intractable pain, unresponsive to other opioid analgesics, or epidural or spinal opiates; has also been used for pediatric chronic pain syndromes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Neuropathic pain:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral: Children and Adolescents: Some centers use the following doses (Galloway, 2000): Initial: 2",
"     <b>",
"      mcg",
"     </b>",
"     /kg/dose every 4-6 hours; increase incrementally over several days; range: 2-4",
"     <b>",
"      mcg",
"     </b>",
"     /kg/dose every 4-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Transdermal: Children and Adolescents: May be switched to the transdermal delivery system after oral therapy is titrated to an optimal and stable dose; a transdermal dose approximately equivalent to the total oral daily dose may be used (Galloway, 2000; Hunt, 1990).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Tic disorders and Tourette's syndrome:",
"     </b>",
"     Initial: 0.025-0.05 mg/day; gradual titration to 3-4 times daily schedule using small increments (0.025 mg); target daily dose: 0.2-0.3 mg/day; doses up to 0.4 mg/day have been reported (Swain, 2007; The Tourette's Syndrome Study Group, 2002)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hypertension:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Immediate release: Initial dose: 0.1 mg twice daily, usual maintenance dose: 0.2-1.2 mg/day in 2-4 divided doses; maximum recommended dose: 2.4 mg/day; usual dosage range (JNC 7): 0.1-0.8 mg/day in 2 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Conversion from transdermal to oral: After transdermal patch removal, therapeutic clonidine levels persist for ~8 hours and then slowly decrease over several days. Consider starting oral clonidine no sooner than 8 hours after patch removal.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Transdermal: Applied once weekly as transdermal delivery system; begin therapy with 0.1 mg/day patch applied once every 7 days; increase by 0.1 mg/day at 1-2 week intervals based on response; hypotensive action may not begin until 2-3 days after initial application; doses &gt;0.6 mg/day do not improve efficacy; usual dosage range (JNC 7): 0.1-0.3 mg/day patch applied once weekly.",
"     <b>",
"      Note:",
"     </b>",
"     If transitioning from oral to transdermal therapy, overlap oral regimen for 1-2 days; transdermal route takes 2-3 days to achieve therapeutic effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Conversion from oral to transdermal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Day 1: Place Catapres-TTS&reg; 1; administer 100% of oral dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Day 2: Administer 50% of oral dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Day 3: Administer 25% of oral dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Day 4: Patch remains; no further oral supplement necessary",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Analgesia:",
"     </b>",
"     Epidural (continuous infusion): Reserved for cancer patients with severe intractable pain, unresponsive to other opioid analgesics: Initial: 30",
"     <b>",
"      mcg",
"     </b>",
"     /",
"     <b>",
"      hour",
"     </b>",
"     ; titrate as required for relief of pain or presence of side effects; minimal experience with doses &gt;40",
"     <b>",
"      mcg",
"     </b>",
"     /",
"     <b>",
"      hour",
"     </b>",
"     ; should be considered an adjunct to intraspinal opioid therapy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Children and Adolescents: Oral [extended release (Kapvay)], epidural: The manufacturer recommends dosage adjustment according to degree of renal impairment; however, there are no specific dosage adjustment provided in the labeling (has not been studied); bradycardia, sedation, and hypotension may be more likely to occur in patients with renal failure; consider using doses at the lower end of the dosage range; monitor patients closely.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Adults: Oral (immediate release), transdermal, epidural: The manufacturer recommends dosage adjustment according to degree of renal impairment; however, no specific dosage adjustment provided. Bradycardia, sedation, and hypotension may be more likely to occur in patients with renal failure; half-life significantly prolonged in patients with severe renal failure; consider use of lower initial doses and monitor closely.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Hemodialysis: Not dialyzable  (0% to 5%); supplemental dose is not necessary. Oral antihypertensive drugs given preferentially at night may reduce the nocturnal surge of blood pressure and minimize the intradialytic hypotension that may occur when taken the morning before a dialysis session (K/DOQI, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Dosing  adjustment in hepatic impairment:",
"     </b>",
"     There are no dosage adjustments provided in the manufacturer labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F153455\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride [epidural, preservative free]: 100 mcg/mL (10 mL); 500 mcg/mL (10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Duraclon&reg;: 100 mcg/mL (10 mL); 500 mcg/mL (10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Patch, transdermal: 0.1 mg/24 hours (4s); 0.2 mg/24 hours (4s); 0.3 mg/24 hours (4s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Catapres-TTS&reg;-1: 0.1 mg/24 hours (4s) [contains metal]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Catapres-TTS&reg;-2: 0.2 mg/24 hours (4s) [contains metal]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Catapres-TTS&reg;-3: 0.3 mg/24 hours (4s) [contains metal]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride: 0.1 mg, 0.2 mg, 0.3 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Catapres&reg;: 0.1 mg, 0.2 mg, 0.3 mg [scored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, extended release, oral, as hydrochloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Kapvay&reg;: 0.1 mg, 0.2 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, extended release, oral, as hydrochloride [dose-pack]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Kapvay&reg;: 0.1 mg AM dose, 0.2 mg PM dose",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F153441\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes extended release tablets",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1051811\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Epidural: Not for I.V. use. Dilute the 500 mcg/mL product with preservative free NS to a final concentration of 100 mcg/mL prior to use; visually inspect for particulate matter and discoloration prior to administration (whenever permitted by container and solution). Do not discontinue clonidine abruptly; if needed, gradually reduce dose over 2-4 days to avoid withdrawal symptoms.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: May be administered without regard to meals. Swallow extended release formulations whole; do not crush or chew. Kapvay&trade; should not be split. Do not discontinue clonidine abruptly; if needed, gradually reduce immediate release dose over 2-4 days to avoid rebound hypertension; extended release formulation (Kapvay&trade;) should be tapered in decrements of &le;0.1 mg every 3-7 days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Transdermal: Patches should be applied at bedtime to a clean, hairless area of the upper arm or chest; rotate patch sites weekly in adults; in children, the patch may need to be changed more frequently (eg, every 3-5 days); in adults, redness under patch may be reduced if a topical corticosteroid spray is applied to the area before placement of the patch (Tom,1994);",
"     <b>",
"      Note:",
"     </b>",
"     Transdermal patch is a membrane-controlled system; do",
"     <b>",
"      not",
"     </b>",
"     cut the patch to deliver partial doses; rate of drug delivery, reservoir contents, and adhesion may be affected if cut; if partial dose is needed, surface area of patch can be blocked proportionally using adhesive bandage (Lee, 1997).",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F153541\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in NS",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Epidural formulation is",
"     <b>",
"      NOT",
"     </b>",
"     for I.V. administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Aminophylline, dobutamine, dopamine, epinephrine, fentanyl, labetalol, lorazepam, magnesium sulfate, nitroglycerin, norepinephrine, potassium chloride, theophylline, verapamil.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Midazolam.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Bupivacaine, bupivacaine with fentanyl, bupivacaine with morphine, fentanyl, fentanyl with lidocaine, heparin, ketamine with tetracaine, lidocaine, tetracaine, ziconotide.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Morphine.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1051802\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Immediate release tablets: Store at 25&deg;C (77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F); dispense in tightly closed, light-resistant container.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Kapvey&trade; extended release tablets: Store at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); dispense in tightly closed, light-resistant container.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Transdermal product: Store below 86&deg;F (30&deg;C)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Epidural formulation: Store at 25&deg;C (77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F).",
"     <b>",
"      Preservative free:",
"     </b>",
"     Discard unused portion; do not admix with diluent (NS) containing preservative",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1051810\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Immediate release: Management of hypertension (monotherapy or as adjunctive therapy) (FDA approved in adults); has also been used for the treatment of attention-deficit/hyperactivity disorder, Tourette syndrome and tic disorders, neonatal abstinence syndrome (opioid withdrawal), and as an aid in the diagnosis of pheochromocytoma and growth hormone deficiency",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Extended release: Kapvay&trade;: Treatment of attention deficit hyperactivity disorder (ADHD) (monotherapy or as adjunctive therapy) (FDA approved in ages 6-17 years)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Parenteral: Epidural (Duraclon&reg;): For continuous epidural administration as adjunctive therapy with opioids for treatment of severe cancer pain in patients tolerant to or unresponsive to opioids alone; epidural clonidine is generally more effective for neuropathic pain and less effective (or possibly ineffective) for somatic or visceral pain [FDA approved in pediatric patients (age not specified) and adults]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Transdermal patch: Management of hypertension (monotherapy or as adjunctive therapy) (FDA approved in adults)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F153543\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       CloNIDine may be confused with Clomid&reg;, clomiPHENE, clonazePAM, cloZAPine, KlonoPIN&reg;, quiNIDine",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Catapres&reg; may be confused with Cataflam&reg;, Combipres",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication (epidural administration) among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - low; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Administration issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Use caution when interpreting dosing information. Pediatric dose for epidural infusion expressed as mcg/kg/",
"       <b>",
"        hour",
"       </b>",
"       .",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Transdermal patch may contain conducting metal (eg, aluminum); remove patch prior to MRI. Errors have occurred when the inactive, optional adhesive cover has been applied instead of the active clonidine-containing patch.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F153540\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Oral, Transdermal:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Arrhythmia, atrioventricular block, bradycardia, chest pain, CHF, ECG abnormalities, flushing, orthostatic hypotension, pallor, palpitation, Raynaud&rsquo;s phenomenon, syncope, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Aggression, agitation, anxiety, behavioral changes, CVA, delirium, delusional perception, dizziness, drowsiness, fatigue, fever, hallucinations (visual and auditory), headache, insomnia, irritability, lethargy, malaise, mental depression, nervousness, nightmares, restlessness, sedation, vivid dreams",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Allergic contact sensitization (transdermal), alopecia, angioedema, blanching (transdermal), burning (transdermal), contact dermatitis (transdermal), edema, excoriation (transdermal), generalized macular rash, hives, hyperpigmentation (transdermal), localized hypopigmentation (transdermal), papules (transdermal), rash, throbbing (transdermal), transient localized skin reactions characterized by pruritus and erythema (transdermal), urticaria, vesiculation (transdermal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Creatine phosphokinase increased (transient; oral), gynecomastia, hyperglycemia (transient; oral), libido decreased, sexual dysfunction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain (oral), anorexia, constipation, diarrhea, nausea, parotid gland pain (oral), parotitis (oral), pseudo-obstruction (oral), taste perversion, throat pain, vomiting, weight gain, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Dysuria, enuresis, erectile dysfunction, nocturia, urinary retention",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Thrombocytopenia (oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Hepatitis, liver function test (mild transient abnormalities)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, leg cramps, myalgia, numbness (localized, transdermal), pain in extremities, paresthesia, tremor, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Accommodation disorder, blurred vision, burning eyes, dry eyes, lacrimation decreased/increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Otic: Ear pain, otitis media",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Renal: Pollakiuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Asthma, epistaxis, nasal congestion, nasal dryness, nasopharyngitis, respiratory tract infection, rhinorrhea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome, thirst, withdrawal syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Epidural: Note:",
"     </b>",
"     The following adverse events occurred more often than placebo in cancer patients with intractable pain being treated with concurrent epidural morphine.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Cardiovascular: Chest pain, hypotension, orthostatic hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Central nervous system: Confusion, dizziness, hallucinations",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Gastrointestinal: Nausea/vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Otic: Tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1051816\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to clonidine hydrochloride or any component; epidural injection is contraindicated in patients receiving anticoagulation therapy and in patients with a bleeding diathesis or an infection at the injection site. Administration of epidural clonidine above the C",
"     <sub>",
"      4",
"     </sub>",
"     dermatome is contraindicated.",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1051798\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dosage modification is required in patients with renal impairment; use with caution in cerebrovascular disease, coronary insufficiency, recent MI, renal impairment, sinus node dysfunction, and conduction disturbances. Use with caution in patients concurrently receiving agents known to reduce SA node function and/or AV nodal conduction (eg, digoxin, diltiazem, metoprolol, verapamil); may increase risk of serious bradycardia. Monitor patients for signs of depression (especially those with a history of affective disorders). Transdermal patch may contain conducting metal (eg, aluminum) which may cause a burn to the skin during an MRI scan; remove patch prior to MRI; reapply patch after scan is completed. Due to the potential for altered electrical conductivity, remove transdermal patch before cardioversion or defibrillation. Localized contact sensitization to the transdermal system has been reported; in these patients, allergic reactions (eg, generalized rash, urticaria, angioedema) have also occurred following subsequent substitution of oral therapy. May cause significant xerostomia; may cause eye dryness in patients who wear contact lenses. In pediatric patients, epidural clonidine should be reserved for cancer patients with severe intractable pain, unresponsive to other analgesics, or epidural or spinal opiates.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1051797\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not abruptly discontinue as rapid increase in blood pressure and symptoms of sympathetic overactivity (such as increased heart rate, tremors, agitation, anxiety, insomnia, sweating, palpitations) may occur. Since children commonly have gastrointestinal illnesses with vomiting, they are susceptible to hypertensive episodes due to abrupt inability to take oral medication. If need to discontinue clonidine, taper oral immediate release or epidural gradually over 2-4 days to avoid rebound hypertension. In patients receiving both a beta-blocker and clonidine, withdraw the beta-blocker several days before the gradual tapering of clonidine. In children and adolescents, extended release formulation (Kapvay&trade;) should be tapered in decrements of &le;0.1 mg every 3-7 days. For surgical patients, discontinue oral immediate release formulations within 4 hours of surgery and restart as soon as possible afterwards; discontinue oral extended release formulations up to 28 hours prior to surgery, then restart the following day; monitor blood pressure closely during surgery; additional therapy to control blood pressure may be needed. Clonidine causes CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery, driving). Sedating effects may be potentiated when used with other CNS-depressant drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     The American Heart Association recommends that all children diagnosed with ADHD who may be candidates for medication, such as clonidine, should have a thorough cardiovascular assessment prior to initiation of therapy. These recommendations are based upon reports of serious cardiovascular adverse events (including sudden death) in patients (both children and adults) taking usual doses of stimulant medications. Most of these patients were found to have underlying structural heart disease (eg, hypertrophic obstructive cardiomyopathy). This assessment should include a combination of thorough medical history, family history, and physical examination. An ECG is not mandatory but should be considered.",
"     <b>",
"      Note:",
"     </b>",
"     ECG abnormalities and 4 cases of sudden cardiac death have been reported in children receiving clonidine with methylphenidate; reduce dose of methylphenidate by 40% when used concurrently with clonidine; consider ECG monitoring. In patients with ADHD, clonidine may cause hypotension and bradycardia; use with caution in patients with history of hypotension, heartblock, bradycardia, cardiovascular disease, syncope, conditions predisposing to syncope (including orthostatic hypotension, dehydration), or receiving concomitant antihypertensive therapy. Patients should be advised to avoid becoming dehydrated or overheated. Heart rate and blood pressure should be monitored at initiation of therapy, with any dose increase, and periodically during therapy.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Epidural clonidine is not recommended for perioperative, obstetrical, or postpartum pain [due to the risk of hemodynamic instability (hypotension, bradycardia)]",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     , in patients with severe cardiovascular disease, or those who are hemodynamically unstable. In all patients, use epidural clonidine with caution due to the potential for severe hypotension, especially in women and those of low body weight. Most hypotensive episodes occur within the first 4 days of initiation; however, episodes may occur throughout the duration of therapy. Epidural clonidine may cause bradycardia (symptomatic bradycardia may be treated with atropine); sedation, respiratory depression, and ventilatory abnormalities may occur with high epidural doses. Epidural formulation (500 mcg/mL) must be diluted prior to administration",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; should be administered via continuous epidural infusion device; monitor closely for catheter-related infection, such as meningitis or epidural abscess.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Formulations of clonidine (immediate release vs extended release) are not interchangeable on a mg:mg basis due to different pharmacokinetic profiles.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F153450\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alfuzosin: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amifostine: Antihypertensives may enhance the hypotensive effect of Amifostine.  Management: When amifostine is used at chemotherapy doses, antihypertensive medications should be withheld for 24 hours prior to amifostine administration. If antihypertensive therapy can not be withheld, amifostine should not be administered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidepressants (Alpha2-Antagonist): May diminish the antihypertensive effect of Alpha2-Agonists. Management: Consider avoiding concurrent use.  If these combinations cannot be avoided, monitor for decreased effects of alpha2-agonists if an alpha2-antagonist is initiated/dose increased, or increased effects if an alpha2-antagonist is discontinued/dose decreased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antihypertensives: May enhance the hypotensive effect of other Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Alpha2-Agonists may enhance the AV-blocking effect of Beta-Blockers. Sinus node dysfunction may also be enhanced. Beta-Blockers may enhance the rebound hypertensive effect of Alpha2-Agonists. This effect can occur when the alpha",
"     <sub>",
"      2",
"     </sub>",
"     -agonist is abruptly withdrawn.  Management: Closely monitor heart rate during treatment with a beta blocker and clonidine. Withdraw beta blockers several days before clonidine withdrawal when possible, and monitor blood pressure closely. Recommendations for other alpha2-agonists are unavailable.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levobunolol; Metipranolol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers (Nondihydropyridine): CloNIDine may enhance the AV-blocking effect of Calcium Channel Blockers (Nondihydropyridine). Sinus node dysfunction may also be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: CloNIDine may enhance the AV-blocking effect of Cardiac Glycosides. Sinus node dysfunction may also be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diazoxide: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypertensive Properties): May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypotensive Properties): May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypotensive Agents: May enhance the adverse/toxic effect of other Hypotensive Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Alpha2-Agonists may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: May enhance the adverse/toxic effect of CloNIDine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphodiesterase 5 Inhibitors: May enhance the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RiTUXimab: Antihypertensives may enhance the hypotensive effect of RiTUXimab.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin/Norepinephrine Reuptake Inhibitors: May diminish the antihypertensive effect of Alpha2-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: May diminish the antihypertensive effect of Alpha2-Agonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Yohimbine: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1051819\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid natural licorice (causes sodium and water retention and increases potassium loss)",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F153451\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F153467\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been observed in some animal reproduction studies. Clonidine crosses the placenta; concentrations in the umbilical cord plasma are similar to those in the maternal serum and concentrations in the amniotic fluid may be 4 times those in the maternal serum.",
"     <b>",
"      [U.S. Boxed Warning]: Epidural clonidine is not recommended for obstetrical or postpartum pain",
"     </b>",
"     due to risk of hemodynamic instability.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1051806\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pressure, heart rate; consider ECG monitoring in patients with history of heart disease or concurrent use of medications affecting cardiac conduction. With epidural administration: Blood pressure, heart rate; pulse oximetry with large bolus doses; monitor infusion pump and catheter tubing for obstruction or dislodgment throughout the course of therapy to decrease risk of inadvertent abrupt discontinuation; monitor closely for catheter-related infection, such as meningitis or epidural abscess.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ADHD: Evaluate patients for cardiac disease prior to initiation of therapy for ADHD with thorough medical history, family history, and physical exam; consider ECG; perform ECG and echocardiogram if findings suggest cardiac disease; promptly conduct cardiac evaluation in patients who develop chest pain, unexplained syncope, or any other symptom of cardiac disease during treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Clonidine tolerance test: In addition to growth hormone concentrations, monitor blood pressure and blood glucose (Huang, 2001)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1051796\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stimulates alpha",
"     <sub>",
"      2",
"     </sub>",
"     -adrenoreceptors in the brain stem, thus activating an inhibitory neuron, resulting in reduced sympathetic outflow, producing a decrease in vasomotor tone and heart rate. Clonidine also acutely stimulates the release of growth hormone in children and adults; however, with long-term use, it does not cause chronic elevation of growth hormone. For the treatment of ADHD, the mechanism of action is unknown; it has been proposed that postsynaptic alpha",
"     <sub>",
"      2A",
"     </sub>",
"     -agonist stimulation regulates subcortical activity in the prefrontal cortex, the area of the brain responsible for emotions, attentions, and behaviors, and causes reduced hyperactivity, impulsiveness, and distractibility.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1051814\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antihypertensive effects:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Onset of action: Oral: Immediate release: 30-60 minutes; Transdermal: Initial application: 2-3 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Maximum effect: Oral: Immediate release:  Within 2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Duration: Oral: Immediate release: 6-10 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Attention-deficit/hyperactivity disorder: Onset of action: 1-2 weeks (AAP, 2011)",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1051815\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Extended release tablets (Kapvay&trade;) are not bioequivalent with immediate release formulations; peak plasma concentrations are 50% lower compared to immediate release formulations",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 2 L/kg; highly lipid soluble; distributes readily into extravascular sites;",
"     <b>",
"      Note:",
"     </b>",
"     Epidurally administered clonidine readily distributes into plasma via the epidural veins and attains clinically significant systemic concentrations.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 20% to 40%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic to inactive metabolites; undergoes enterohepatic recirculation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Oral: Immediate release: 75% to 85%; extended release (Kapvay&trade;): 89% (compared to immediate release formulation) (Cunningham, 1994)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Oral: Immediate release: 3-5 hours; extended release: 7-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Serum half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Neonates: 44-72 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children: 8-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Normal renal function: 12-16 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Renal impairment: &le;41 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Epidural administration: CSF half-life: 1.3 &plusmn; 0.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Urine (40% to 60% as unchanged drug)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dialysis: Not dialyzable (0% to 5%)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1051804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?20/7/20598?source=see_link\">",
"      see \"Clonidine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid alcohol; may cause drowsiness and impair ability to perform activities requiring mental alertness or physical coordination; do not stop drug abruptly; may cause dry mouth",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1051817\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Clonidine-induced symptomatic bradycardia may be treated with atropine. Clonidine hydrochloride 0.1 mg is equal to 0.087 mg of the free base. Medications used to treat ADHD should be part of a total treatment program that may include other components, such as psychological, educational, and social measures. Long-term usefulness of clonidine for the treatment of ADHD should be periodically re-evaluated in patients receiving the drug for extended periods of time.",
"    </p>",
"   </div>",
"   <div class=\"block exp drugH1Div\" id=\"F11339546\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Extemporaneous Preparations",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     A 0.1 mg/mL oral suspension may be made from tablets. Crush thirty 0.2 mg tablets in a glass mortar and reduce to a fine powder. Slowly add 2 mL Purified Water USP and mix to a uniform paste. Slowly add Simple Syrup, NF in 15 mL increments; transfer to a calibrated bottle, rinse mortar with vehicle, and add quantity of vehicle sufficient to make 60 mL. Label \"shake well\" and \"refrigerate\". Stable for 28 days when stored in amber glass bottles and refrigerated.",
"    </p>",
"    <div class=\"reference\">",
"     Levinson ML and Johnson CE, \"Stability of an Extemporaneously Compounded Clonidine Hydrochloride Oral Liquid,\" Am J Hosp Pharm, 1992, 49(1):122-5.",
"     <span class=\"pubmed-id\">",
"      1570852",
"     </span>",
"    </div>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics, \"ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2011; 128(5): 1-16.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics/American Heart Association Clarification of Statement on Cardiovascular Evaluation and Monitoring of Children and Adolescents With Heart Disease Receiving Medications for ADHD. Available at file://www.aap.org/pressroom/aap-ahastatement.htm",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chafin CC, Hovinga CA, and Phelps SJ, \"Clonidine in the Treatment of Attention Deficit Hyperactivity Disorder,\"",
"      <i>",
"       Journal of Pediatric Pharmacy Practice",
"      </i>",
"      , 1999, 4(6):308-15.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chobanian AV, Bakris GL, Black HR, et al, \"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report,\"",
"      <i>",
"       JAMA",
"      </i>",
"      , 2003, 289(19):2560-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/12748199/pubmed\" id=\"12748199\" target=\"_blank\">",
"        12748199",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cunningham FE, Baughman VL, Peters J, et al, \"Comparative Pharmacokinetics of Oral Versus Sublingual Clonidine,\"",
"      <i>",
"       J Clin Anesth",
"      </i>",
"      , 1994, 6(5):430-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/7986518/pubmed\" id=\"7986518\" target=\"_blank\">",
"        7986518",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Galloway KS and Yaster M, \"Pain and Symptom Control in Terminally Ill Children,\"",
"      <i>",
"       Pediatr Clin North Am",
"      </i>",
"      , 2000, 47(3):711-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/10835999/pubmed\" id=\"10835999\" target=\"_blank\">",
"        10835999",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hart-Santora D and Hart LL, \"Clonidine in Attention Deficit Hyperactivity Disorder,\"",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1992, 26(1):37-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/1606344/pubmed\" id=\"1606344\" target=\"_blank\">",
"        1606344",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Huang C, Banerjee K, Sochett E, et al, \"Hypoglycemia Associated With Clonidine Testing for Growth Hormone Deficiency,\"",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 2001, 139(2):323-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/11487765/pubmed\" id=\"11487765\" target=\"_blank\">",
"        11487765",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hudak ML and Tan RC, \"Neonatal Drug Withdrawal,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2012, 129(2):e540-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/22291123/pubmed\" id=\"22291123\" target=\"_blank\">",
"        22291123",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hunt RD, Capper L, and O'Connell P, \"Clonidine in Child and Adolescent Psychiatry,\"",
"      <i>",
"       J Child Adol Psychpharm",
"      </i>",
"      , 1990, 1(1):87-102.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hunt RD, Minderaa RB, and Cohen DJ, \"The Therapeutic Effect of Clonidine in Attention Deficit Disorder With Hyperactivity: A Comparison With Placebo and Methylphenidate,\"",
"      <i>",
"       Psychopharmacol Bull",
"      </i>",
"      , 1986, 22(1):229-35.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/3523578/pubmed\" id=\"3523578\" target=\"_blank\">",
"        3523578",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kavey RE, Daniels SR, and Flynn JT, \"Management of High Blood Pressure in Children and Adolescents,\"",
"      <i>",
"       Cardiol Clin",
"      </i>",
"      , 2010, 28(4):597-607.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/20937444/pubmed\" id=\"20937444\" target=\"_blank\">",
"        20937444",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      K/DOQI Workgroup, \"K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients,\"",
"      <i>",
"       Am J Kidney Dis",
"      </i>",
"      , 2005, 45(4 Suppl 3):S46-57.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/15806502/pubmed\" id=\"15806502\" target=\"_blank\">",
"        15806502",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lanes R and Hurtado E, \"Oral Clonidine &minus; An Effective Growth Hormone-Releasing Agent in Prepubertal Subjects,\"",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1982, 100(5):710-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/7040621/pubmed\" id=\"7040621\" target=\"_blank\">",
"        7040621",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lee HA and Anderson PO, \"Giving Partial Doses of Transdermal Patches,\"",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 1997, 54(15):1759-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/9262751/pubmed\" id=\"9262751\" target=\"_blank\">",
"        9262751",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Leikin JB, Mackendrick WP, Maloney GE, et al, \"Use of Clonidine in the Prevention and Management of Neonatal Abstinence Syndrome,\"",
"      <i>",
"       Clin Toxicol (Phila)",
"      </i>",
"      , 2009, 47(6):551-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/19566381/pubmed\" id=\"19566381\" target=\"_blank\">",
"        19566381",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Heart, Lung, and Blood Institute, &ldquo;Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents,&rdquo;",
"      <i>",
"       Clinical Practice Guidelines",
"      </i>",
"      , 2011, National Institutes of Health. Available at",
"      <a href=\"file://www.nhlbi.nih.gov/guidelines/cvd_ped/peds_guidelines_full.pdf\" target=\"_blank\">",
"       file://www.nhlbi.nih.gov/guidelines/cvd_ped/peds_guidelines_full.pdf",
"      </a>",
"      . Date accessed: June 11, 2012.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National High Blood Pressure Education Program (NHBPEP) Working Group on High Blood Pressure in Children and Adolescents, \"The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2004, 114(2 Suppl 4th Report):555-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/15286277/pubmed\" id=\"15286277\" target=\"_blank\">",
"        15286277",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pliszka S; AACAP Work Group on Quality Issues, \"Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder,\"",
"      <i>",
"       J Am Acad Child Adolesc Psychiatry",
"      </i>",
"      , 2007, 46(7):894-921.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/17581453/pubmed\" id=\"17581453\" target=\"_blank\">",
"        17581453",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Richmond EJ and Rogol AD, \"Growth Hormone Deficiency in Children,\"",
"      <i>",
"       Pituitary",
"      </i>",
"      , 2008, 11(2):115-20.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rocchini AP, \"Childhood Hypertension: Etiology, Diagnosis, and Treatment,\"",
"      <i>",
"       Pediatr Clin North Am",
"      </i>",
"      , 1984, 31(6):1259-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/6390314/pubmed\" id=\"6390314\" target=\"_blank\">",
"        6390314",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Scahill L, \"Alpha-2 Adrenergic Agonists in Attention Deficit Hyperactivity Disorder,\"",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 2009, 154:S32-7.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sinaiko AR, \"Pharmacologic Management of Childhood Hypertension,\"",
"      <i>",
"       Pediatr Clin North Am",
"      </i>",
"      , 1993, 40(1):195-212.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/8417406/pubmed\" id=\"8417406\" target=\"_blank\">",
"        8417406",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Swain JE, Scahill L, Lombroso PJ, et al, \"Tourette Syndrome and Tic Disorders: A Decade of Progress,\"",
"      <i>",
"       J Am Acad Child Adolesc Psychiatry",
"      </i>",
"      , 2007, 46(8):947-68.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/17667475/pubmed\" id=\"17667475\" target=\"_blank\">",
"        17667475",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tom GR and Premer M, \"Hydrocortisone Cream in Clonidine Patch Dermatitis,\"",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1994, 28(7-8):889-90.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/7949510/pubmed\" id=\"7949510\" target=\"_blank\">",
"        7949510",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tourette's Syndrome Study Group, \"Treatment of ADHD in Children With Tics: A Randomized Controlled Trial,\"",
"      <i>",
"       Neurology",
"      </i>",
"      , 2002, 58(4):527-36.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/11865128/pubmed\" id=\"11865128\" target=\"_blank\">",
"        11865128",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vetter VL, Elia J, Erickson C, et al, \"Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2008, 117(18):2407-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/14/13545/abstract-text/18427125/pubmed\" id=\"18427125\" target=\"_blank\">",
"        18427125",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13171 Version 42.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-219.243.220.100-9E6818F356-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_14_13545=[""].join("\n");
var outline_f13_14_13545=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708678\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153485\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153486\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051807\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12669157\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051799\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153455\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153441\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051811\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153541\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051802\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051810\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153543\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153540\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051816\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051798\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051797\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299067\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153450\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051819\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153451\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153467\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051806\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051796\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051814\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051815\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051804\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051817\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11339546\">",
"      Extemporaneous Preparations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13171\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13171|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?18/53/19289?source=related_link\">",
"      Clonidine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?20/7/20598?source=related_link\">",
"      Clonidine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_14_13546="Subcorneal pustular dermatosis histopathology";
var content_f13_14_13546=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F67144%7EDERM%2F79570&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F67144%7EDERM%2F79570&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Subcorneal pustular dermatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Subcorneal blister formation in subcorneal pustular dermatosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Subcorneal pustular dermatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 289px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A subcorneal neutrophilic pustule is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_14_13546=[""].join("\n");
var outline_f13_14_13546=null;
var title_f13_14_13547="Lower extremity splints";
var content_f13_14_13547=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F53065&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F53065&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Lower extremity splints",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Splint",
"       </td>",
"       <td class=\"subtitle1\">",
"        Indication",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Knee splint",
"       </td>",
"       <td>",
"        Knee injuries",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Jones compression",
"       </td>",
"       <td>",
"        Knee and calf injuries",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Posterior ankle splint",
"       </td>",
"       <td>",
"        Distal leg, ankle, tarsal, and metatarsal fractures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduced dislocations, severe sprains",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stirrup splint",
"       </td>",
"       <td>",
"        Ankle fractures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Bulky foot compression dressing",
"       </td>",
"       <td>",
"        Calcaneal fractures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Foot injuries",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Buddy taping",
"       </td>",
"       <td>",
"        Phalangeal fractures of the toes",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_14_13547=[""].join("\n");
var outline_f13_14_13547=null;
var title_f13_14_13548="Serial CT frequency";
var content_f13_14_13548=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F69395&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F69395&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommendations for follow-up and management of nodules detected incidentally at nonscreening computed tomography (CT)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Nodule size (mm)*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Low-risk patient",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        High-risk patient",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &le;4",
"       </td>",
"       <td>",
"        No follow-up needed",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        Follow-up CT at 12 months; if unchanged, no further follow-up",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;4 to 6",
"       </td>",
"       <td>",
"        Follow-up CT at 12 months; if unchanged, no further follow-up",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        Initial follow-up CT at 6 to 12 months then at 18 to 24 months if no change",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;6 to 8",
"       </td>",
"       <td>",
"        Initial follow-up CT at 6 to 12 months then at 18 to 24 months if no change",
"       </td>",
"       <td>",
"        Initial follow-up CT at 3 to 6 months then at 9 to 12 and 24 months if no change",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;8",
"       </td>",
"       <td>",
"        Follow-up CT at around 3, 9, and 24 months, dynamic contrast-enhanced CT, PET, and/or biopsy",
"       </td>",
"       <td>",
"        Same as for low-risk patient",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Note: Newly detected indeterminate nodule in persons 35 years of age or older.",
"    <div class=\"footnotes\">",
"     CT: computed tomography; PET: positron emission tomography.",
"     <br>",
"      * Average of length and width.",
"      <br>",
"       &bull; Minimal or absent history of smoking and of other known risk factors.",
"       <br>",
"        &Delta; History of smoking or of other known risk factors.",
"        <br>",
"         &loz; The risk of malignancy in this category (&lt;1 percent) is substantially less than that in a baseline CT scan of an asymptomatic smoker.",
"         <br>",
"          &sect; Nonsolid (ground-glass) or partly solid nodules may require longer follow-up to exclude indolent adenocarcinoma.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: MacMahon H, Austin JM, Gordon G, et al. Guidelines for Management of Small Pulmonary Nodules Detected on CT Scans: A Statement from the Fleischner Society. (Editorial). Radiology 2005; 237:395. Copyright &copy; 2005 Radiological Society of North America.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_14_13548=[""].join("\n");
var outline_f13_14_13548=null;
var title_f13_14_13549="Periodic paralysis";
var content_f13_14_13549=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F65215&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F65215&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Periodic paralysis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       &nbsp;",
"      </td>",
"      <td class=\"subtitle1\">",
"       Hypokalemic Periodic Paralysis",
"      </td>",
"      <td class=\"subtitle1\">",
"       Thyrotoxic Periodic Paralysis",
"      </td>",
"      <td class=\"subtitle1\">",
"       Hyperkalemic Periodic Paralysis",
"      </td>",
"      <td class=\"subtitle1\">",
"       Andersen Syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Age at onset",
"       </strong>",
"      </td>",
"      <td>",
"       First or second decade",
"      </td>",
"      <td>",
"       &gt;20 years",
"      </td>",
"      <td>",
"       First decade",
"      </td>",
"      <td>",
"       First or second decade",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Attack frequency",
"       </strong>",
"      </td>",
"      <td>",
"       Infrequent (a few times a year)",
"      </td>",
"      <td>",
"       Infrequent",
"      </td>",
"      <td>",
"       Frequent (up to several a day)",
"      </td>",
"      <td>",
"       Monthly",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Attack duration",
"       </strong>",
"      </td>",
"      <td>",
"       Hours to days",
"      </td>",
"      <td>",
"       Hours to days",
"      </td>",
"      <td>",
"       Minutes to hours",
"      </td>",
"      <td>",
"       Days",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Precipitants",
"       </strong>",
"      </td>",
"      <td>",
"       <p>",
"        Exercise",
"       </p>",
"       <p>",
"        Carbohydrate load",
"       </p>",
"       <p>",
"        Stress",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Exercise",
"       </p>",
"       <p>",
"        Carbohydrate load",
"       </p>",
"       <p>",
"        Stress",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Exercise",
"       </p>",
"       <p>",
"        Fasting",
"       </p>",
"       <p>",
"        Stress",
"       </p>",
"       <p>",
"        K-rich food",
"       </p>",
"      </td>",
"      <td>",
"       Rest after exercise",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Potassium level during attack",
"       </strong>",
"      </td>",
"      <td>",
"       Low",
"      </td>",
"      <td>",
"       Low",
"      </td>",
"      <td>",
"       Normal or elevated",
"      </td>",
"      <td>",
"       Low, normal, or elevated",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Associated features",
"       </strong>",
"      </td>",
"      <td>",
"       Later onset myopathy",
"      </td>",
"      <td>",
"       <p>",
"        Symptoms of thyrotoxicosis",
"       </p>",
"       <p>",
"        Low TSH with high T4 or high T3",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Myotonia on examination and/or EMG",
"       </p>",
"       <p>",
"        Later onset myopathy",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Dysmorphic features",
"       </p>",
"       <p>",
"        Ventricular arrhythmias",
"       </p>",
"       <p>",
"        Long QT interval",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Etiology",
"       </strong>",
"      </td>",
"      <td>",
"       Autosomal dominant inherited defect in calcium or sodium ion channel on muscle membrane",
"      </td>",
"      <td>",
"       <p>",
"        Thyrotoxicosis",
"       </p>",
"       <p>",
"        Possible inherited predisposition",
"       </p>",
"      </td>",
"      <td>",
"       Autosomal dominant inherited defect of sodium ion channel on muscle membrane",
"      </td>",
"      <td>",
"       Autosomal dominant inherited defect of inward rectifying potassium channel",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Penetrance",
"       </strong>",
"      </td>",
"      <td>",
"       Nonpenetrance common, especially in women",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       High",
"      </td>",
"      <td>",
"       Nonpenetrance and incomplete penetrance common",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Epidemiology",
"       </strong>",
"      </td>",
"      <td>",
"       Clinical expression in men more frequent than women",
"      </td>",
"      <td>",
"       Highest incidence in Asians and in men more than women",
"      </td>",
"      <td>",
"       Sexes equally affected",
"      </td>",
"      <td>",
"       Marked intrafamilial phenotypic variation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Preventive treatment",
"       </strong>",
"      </td>",
"      <td>",
"       <p>",
"        Carbonic anhydrase inhibitors",
"       </p>",
"       <p>",
"        Potassium-sparing diuretics",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Euthyroid state",
"       </p>",
"       <p>",
"        Propranolol",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Carbonic anhydrase inhibitors",
"       </p>",
"       <p>",
"        Thiazide diuretics",
"       </p>",
"       <p>",
"        Inhaled beta-agonists as needed",
"       </p>",
"      </td>",
"      <td>",
"       Carbonic anhydrase inhibitors",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Abbreviations: K = potassium; TSH = thyroid stimulating hormone; T4 = thyroid hormone (thyroxine); T3 = thyroid hormone (triiodothyronine); EMG = electromyography",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_14_13549=[""].join("\n");
var outline_f13_14_13549=null;
var title_f13_14_13550="Outcome SWI VO2";
var content_f13_14_13550=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F56121&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F56121&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 490px\">",
"   <div class=\"ttl\">",
"    Stroke work index predicts outcome in patients with heart failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 470px; height: 222px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In a study of 219 patients with heart failure followed for 19 months, a peak exercise stroke work index (peak ex SWI) &gt;30 gm/m2, derived from Swan-Ganz catheter measurements, was the most powerful predictor of two year survival (91 versus 54 percent for peak ex SWI &le;30 gm/m2). Among patients with a low peak VO2 (&lt;14 ml/kg/min), those with a normal peak ex SWI (&gt;30 gm/m2) had an excellent survival (87 versus 58 percent for SWI &lt;30 gm/m2).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Metra, M, Faggiano, P, D'Aloia, A, et al. J Am Coll Cardiol 1999; 33:943.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_14_13550=[""].join("\n");
var outline_f13_14_13550=null;
var title_f13_14_13551="Cholesteatoma of the middle ear";
var content_f13_14_13551=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F66686&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F66686&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cholesteatoma of the middle ear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 320px; height: 319px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cholesteatoma (arrow) is a growth of desquamated, stratified, squamous epithelium.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission from Nikolas H Blevins, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_14_13551=[""].join("\n");
var outline_f13_14_13551=null;
